HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
139476.0,203250,2114-11-03 10:05:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   Mitral Valve
   thrombus
   24 Hour Events:
   Patient had increased O2 requirement overnight, worsening rales on
   exam. Patient had started BiPap, then was Diuresed.  O2 requirement
   improved.  R IJ placed as PIVs difficult to place.
   Allergies:
   Lasix (Oral) (Furosemide)
   Hives;
   Codeine
   Rash;
   Ceclor (Oral) (Cefaclor)
   Unknown;
   Keflex (Oral) (Cephalexin Monohydrate)
   Rash;
   Voltaren (Oral) (Diclofenac Sodium)
   Unknown;
   Penicillins
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Heparin Sodium - 1,050 units/hour
   Other ICU medications:
   Pantoprazole (Protonix) - [**2114-11-3**] 03:31 AM
   Furosemide (Lasix) - [**2114-11-3**] 05:04 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2114-11-3**] 09:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.6
   Tcurrent: 37.6
C (99.6
   HR: 110 (67 - 112) bpm
   BP: 105/62(73) {85/38(59) - 119/72(79)} mmHg
   RR: 24 (21 - 33) insp/min
   SpO2: 97%
   Heart rhythm: AF (Atrial Fibrillation)
             Total In:
                                                                    141 mL
                                                                    338 mL
   PO:
                                                                    120 mL
             TF:
   IVF:
                                                                     21 mL
                                                                    338 mL
   Blood products:
   Total out:
                                                                    510 mL
                                                                  1,080 mL
   Urine:
                                                                    510 mL
                                                                  1,080 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -369 mL
                                                                   -742 mL
   Respiratory support
   O2 Delivery Device: Other
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 1,046 (1,046 - 1,046) mL
   PS : 10 cmH2O
   RR (Spontaneous): 32
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ///22/
   Ve: 6.6 L/min
   Physical Examination
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: No JVD
   CARDIAC: RRR, with loud S2, crescendo-decrescendo murmur at LUSB
   LUNGS: Diffuse rales in posterior lung fields
   ABDOMEN: Soft, RLQ TTP.  Voluntary guarding.  No rebound.
   EXTREMITIES: No c/c/e. No femoral bruits.
   Neuro:  CN II-XII intact, with following exceptions. [**2-21**] Plantar
   flexion of L and R LE.  [**3-24**] handgrip on R, [**1-23**] on L.  Absent L sided
   startle reflex, L lid lag and facial droop.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   355 K/uL
   9.0 g/dL
   155 mg/dL
   1.0 mg/dL
   22 mEq/L
   4.0 mEq/L
   23 mg/dL
   113 mEq/L
   144 mEq/L
   25.9 %
   25.0 K/uL
        [image002.jpg]
                            [**2114-11-2**]  05:00 PM
                            [**2114-11-2**]  09:28 PM
                            [**2114-11-3**]  03:10 AM
   WBC
   20.8
   25.0
   Hct
   29.3
   25.9
   Plt
   321
   355
   Cr
   1.0
   1.0
   TropT
   0.05
   Glucose
   130
   155
   Other labs: PT / PTT / INR:16.8/67.9/1.5, CK / CKMB /
   Troponin-T:58//0.05, ALT / AST:33/62, Alk Phos / T Bili:99/0.4, Amylase
   / Lipase:49/53, Differential-Neuts:86.5 %, Lymph:7.7 %, Mono:4.6 %,
   Eos:0.9 %, Lactic Acid:1.3 mmol/L, Albumin:2.9 g/dL, LDH:462 IU/L,
   Ca++:8.1 mg/dL, Mg++:2.1 mg/dL, PO4:1.8 mg/dL
   Assessment and Plan
   ASSESSMENT AND PLAN 66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**])
   with AV and MV valves transferred from OSH with MV thrombosis and GI
   bleed
   .
   # Acute Congestive Heart Failure:  Secondary to Mitral valve thrombus
   and atrial fibrillation.  Patient has high gradient between LA and LV,
   also not filling well secondary to functional stenosis secondary to
   thrombus.
   -          Start low dose Metoprolol IV for HR control to help forward
   flow.
   -          Lasix prn
   Prosthetic Mitral Valve Thrombus:  Echocardiogram consistent with
   thrombus on prosthetic MV valve and fluroscopy shows one leaflet that
   is fixed.  Patient has TTE during admission at [**Hospital1 1817**] three weeks ago
   that was negative for valvular thrombus.  TTE shows gradient pressures
   of Mitral 28/(mean)18 and Aortic 45/(mean)23.  Given the patient had
   recently had a hemorrhagic stroke and recent GI bleed, the management
   will be difficult.  Patient had resumed coumadin on transfer to
   rehabilitation to prevent further clots.  Need to have dialogue with
   surgery if she will be candidate for surgery in the future.
   - Will continue Heparin gtt
   - TEE today
   # GI bleed:  Unclear source, likely lower GI.  HCT dropped from 29 to
   25 this AM and was subsequently transfused
   - GI recs for endoscopy
   - Will transfuse as needed
   - Trend HCT
   # Atrial Fibrillation:  Poorly rate controlled.  Dig level 1.1, likely
   toxic level in this patient in light of her EKG changes.
   - Will start BB
   - Heparin gtt for further thrombus progression
   # CORONARIES:  h/o CAD documented in OSH records, however patient had
   cath in [**2109**] that showed normal coronaries. Pt had STD on EKG possibly
   in setting of GI Bleed/demand or related to digoxin toxicity.
   .
   # PUMP:  Previous TTE at [**Hospital1 1817**] 3 wks ago showed EF of 50% with no
   thrombus, with presence of dilated left atrium.
   - TEE today
   .
   # RLL Pneumonia:  Possible cause of her elevated WBC of 25 this AM.
   Lactate 1.3.  WBC at OSH was elevated.  Afebrile.  Not apparent that
   BCx obtained at OSH.  In context of thrombus, differential includes
   infected thrombus for leukocytosis.
   - BCx and UCx pending
   - Continue Vanco and Meropenem
   - Check CDiff, start IV Flagyl
   .
   # HTN:  BP 108/43.  SBPs on admission in 80s.
   - Start BB.
   .
   # Hypothyroidism:  Continue home synthroid.
   .
   # s/p hemorrhagic stroke:  Patient with neurological deficits on exam.
   Patient at risk for further embolic event with thrombus.
   .
   FEN: Low salt, thickened liquids
   ACCESS: 18 gauge PIV and R IJ
   PROPHYLAXIS:
   -DVT ppx with Hep gtt, IV PPI
   CODE: Full Code.  Will need to be readdressed with family.
   DISPO: CCU for now
   .
   .
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   22 Gauge - [**2114-11-3**] 04:37 AM
   Multi Lumen - [**2114-11-3**] 06:02 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   Mitral Valve
   thrombus
   24 Hour Events:
   Patient had increased O2 requirement overnight, worsening rales on
   exam. Patient had started BiPap, then was Diuresed.  O2 requirement
   improved.  R IJ placed as PIVs difficult to place.
   Allergies:
   Lasix (Oral) (Furosemide)
   Hives;
   Codeine
   Rash;
   Ceclor (Oral) (Cefaclor)
   Unknown;
   Keflex (Oral) (Cephalexin Monohydrate)
   Rash;
   Voltaren (Oral) (Diclofenac Sodium)
   Unknown;
   Penicillins
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Heparin Sodium - 1,050 units/hour
   Other ICU medications:
   Pantoprazole (Protonix) - [**2114-11-3**] 03:31 AM
   Furosemide (Lasix) - [**2114-11-3**] 05:04 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2114-11-3**] 09:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.6
   Tcurrent: 37.6
C (99.6
   HR: 110 (67 - 112) bpm
   BP: 105/62(73) {85/38(59) - 119/72(79)} mmHg
   RR: 24 (21 - 33) insp/min
   SpO2: 97%
   Heart rhythm: AF (Atrial Fibrillation)
             Total In:
                                                                    141 mL
                                                                    338 mL
   PO:
                                                                    120 mL
             TF:
   IVF:
                                                                     21 mL
                                                                    338 mL
   Blood products:
   Total out:
                                                                    510 mL
                                                                  1,080 mL
   Urine:
                                                                    510 mL
                                                                  1,080 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -369 mL
                                                                   -742 mL
   Respiratory support
   O2 Delivery Device: Other
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 1,046 (1,046 - 1,046) mL
   PS : 10 cmH2O
   RR (Spontaneous): 32
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ///22/
   Ve: 6.6 L/min
   Physical Examination
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: No JVD
   CARDIAC: RRR, with loud S2, crescendo-decrescendo murmur at LUSB
   LUNGS: Diffuse rales in posterior lung fields
   ABDOMEN: Soft, RLQ TTP.  Voluntary guarding.  No rebound.
   EXTREMITIES: No c/c/e. No femoral bruits.
   Neuro:  CN II-XII intact, with following exceptions. [**2-21**] Plantar
   flexion of L and R LE.  [**3-24**] handgrip on R, [**1-23**] on L.  Absent L sided
   startle reflex, L lid lag and facial droop.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   355 K/uL
   9.0 g/dL
   155 mg/dL
   1.0 mg/dL
   22 mEq/L
   4.0 mEq/L
   23 mg/dL
   113 mEq/L
   144 mEq/L
   25.9 %
   25.0 K/uL
        [image002.jpg]
                            [**2114-11-2**]  05:00 PM
                            [**2114-11-2**]  09:28 PM
                            [**2114-11-3**]  03:10 AM
   WBC
   20.8
   25.0
   Hct
   29.3
   25.9
   Plt
   321
   355
   Cr
   1.0
   1.0
   TropT
   0.05
   Glucose
   130
   155
   Other labs: PT / PTT / INR:16.8/67.9/1.5, CK / CKMB /
   Troponin-T:58//0.05, ALT / AST:33/62, Alk Phos / T Bili:99/0.4, Amylase
   / Lipase:49/53, Differential-Neuts:86.5 %, Lymph:7.7 %, Mono:4.6 %,
   Eos:0.9 %, Lactic Acid:1.3 mmol/L, Albumin:2.9 g/dL, LDH:462 IU/L,
   Ca++:8.1 mg/dL, Mg++:2.1 mg/dL, PO4:1.8 mg/dL
   Assessment and Plan
   ASSESSMENT AND PLAN 66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**])
   with AV and MV valves transferred from OSH with MV thrombosis and GI
   bleed
   .
   # Acute Congestive Heart Failure:  Secondary to Mitral valve thrombus
   and atrial fibrillation.  Patient has high gradient between LA and LV,
   also not filling well secondary to functional stenosis secondary to
   thrombus.
   -          Start low dose Metoprolol IV for HR control to help forward
   flow.
   -          Lasix prn
   Prosthetic Mitral Valve Thrombus:  Echocardiogram consistent with
   thrombus on prosthetic MV valve and fluroscopy shows one leaflet that
   is fixed.  Patient has TTE during admission at [**Hospital1 1817**] three weeks ago
   that was negative for valvular thrombus.  TTE shows gradient pressures
   of Mitral 28/(mean)18 and Aortic 45/(mean)23.  Given the patient had
   recently had a hemorrhagic stroke and recent GI bleed, the management
   will be difficult.  Patient had resumed coumadin on transfer to
   rehabilitation to prevent further clots.  Need to have dialogue with
   surgery if she will be candidate for surgery in the future.
   - Will continue Heparin gtt
   - TEE today
   # GI bleed:  Unclear source, likely lower GI.  HCT dropped from 29 to
   25 this AM and was subsequently transfused
   - GI recs for endoscopy
   - Will transfuse as needed
   - Trend HCT
   # Atrial Fibrillation:  Poorly rate controlled.  Dig level 1.1, likely
   toxic level in this patient in light of her EKG changes.
   - Will start BB
   - Heparin gtt for further thrombus progression
   # CORONARIES:  h/o CAD documented in OSH records, however patient had
   cath in [**2109**] that showed normal coronaries. Pt had STD on EKG possibly
   in setting of GI Bleed/demand or related to digoxin toxicity.
   .
   # PUMP:  Previous TTE at [**Hospital1 1817**] 3 wks ago showed EF of 50% with no
   thrombus, with presence of dilated left atrium.
   - TEE today
   .
   # RLL Pneumonia:  Possible cause of her elevated WBC of 25 this AM.
   Lactate 1.3.  WBC at OSH was elevated.  Afebrile.  Not apparent that
   BCx obtained at OSH.  In context of thrombus, differential includes
   infected thrombus for leukocytosis.
   - BCx and UCx pending
   - Continue Vanco and Meropenem
   - Check CDiff, start IV Flagyl
   .
   # HTN:  BP 108/43.  SBPs on admission in 80s.
   - Start BB.
   .
   # Hypothyroidism:  Continue home synthroid.
   .
   # s/p hemorrhagic stroke:  Patient with neurological deficits on exam.
   Patient at risk for further embolic event with thrombus.
   .
   FEN: Low salt, thickened liquids
   ACCESS: 18 gauge PIV and R IJ
   PROPHYLAXIS:
   -DVT ppx with Hep gtt, IV PPI
   CODE: Full Code.  Will need to be readdressed with family.
   DISPO: CCU for now
   .
   .
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   22 Gauge - [**2114-11-3**] 04:37 AM
   Multi Lumen - [**2114-11-3**] 06:02 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 66-year-old female who was admitted to the ICU with a diagnosis of Mitral Valve thrombus, atrial fibrillation, and acute congestive heart failure. She has a history of hemorrhagic stroke, gastrointestinal bleed, and coronary artery disease.

The patient's current condition is as follows:

* Vital signs: Tmax 37.6°C, HR 110 bpm, BP 105/62 mmHg, RR 24 insp/min, SpO2 97%.
* Respiratory support: BiPap, CPAP/PSV mode, FiO2 50%, PEEP 5 cmH2O, PIP 16 cmH2O.
* Hemodynamic monitoring: Right and left-sided pulses are present, with no femoral bruits.
* Neurological examination: CN II-XII intact, with exceptions including plantar flexion of the left and right lower extremities, handgrip on the right, and absent left-sided startle reflex, left lid lag, and facial droop.
* Laboratory results: WBC 20.8, Hct 29.3, Plt 321, Cr 1.0, TropT 0.05, Glucose 130, and other lab results as listed.

The patient's medical conditions and potential complications include:

* Acute Congestive Heart Failure: secondary to Mitral valve thrombus and atrial fibrillation.
* Prosthetic Mitral Valve Thrombus: with a gradient pressure of 28/18 mmHg and a mean gradient of 18 mmHg.
* GI bleed: unclear source, likely lower GI, with a Hct drop from 29 to 25 this morning and subsequent transfusion.
* Atrial Fibrillation: poorly rate-controlled, with a Dig level of 1.1, likely toxic level in this patient.
* Coronaries: history of CAD, with a cath in [**2109**] showing normal coronaries, but with STD on EKG possibly related to GI bleed/demand or digoxin toxicity.
* Pump: previous TTE showing EF of 50% with no thrombus, but with dilated left atrium.
* RLL Pneumonia: possible cause of elevated WBC, with lactate 1.3 and WBC at OSH elevated.
* HTN: BP 108/43, with SBPs on admission in the 80s.
* Hypothyroidism: continuing home synthroid.
* s/p hemorrhagic stroke: patient with neurological deficits on exam, at risk for further embolic event with thrombus.

The patient's plan of care includes:

* Start low-dose Metoprolol IV for HR control.
* Lasix prn for fluid management.
* Continue Heparin gtt for thrombus progression.
* TEE today to assess prosthetic Mitral Valve thrombus.
* GI recs for endoscopy to evaluate unclear source of GI bleed.
* Transfuse as needed.
* Trend HCT.
* Start BB for atrial fibrillation.
* Continue Vanco and Meropenem for RLL Pneumonia.
* Check CDiff and start IV Flagyl.
* Start IV Flagyl for RLL Pneumonia.
* Continue home synthroid for hypothyroidism.
* Monitor for further neurological deficits and embolic events.

The patient's code status is Full Code, and she is currently in the ICU for further management and monitoring."
139476.0,203250,2114-11-04 05:42:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2114-11-3**] 12:15 PM
 NON-INVASIVE VENTILATION - START [**2114-11-3**] 06:27 PM
 EKG - At [**2114-11-3**] 08:00 PM
 FEVER - 101.6
F - [**2114-11-3**] 10:00 PM
   TEE showed thrombus increasing in size.  Family meeting: plan not to
   escalate care.  Would make CMO if worsening.  GI recommended CT scan
   when more stable and following lactate.  Tachycardia responded well to
   5 mg metoprolol bolus in AM and PM.  Hypoxic -> ABG, CXR, CPAP o/n.
   Fevers through vanc/[**Last Name (un) 430**].
   Tele: HR improved with metoprolol.  Desats at 11 PM.  Prior to CPAP.
   Allergies:
   Lasix (Oral) (Furosemide)
   Hives;
   Codeine
   Rash;
   Ceclor (Oral) (Cefaclor)
   Unknown;
   Keflex (Oral) (Cephalexin Monohydrate)
   Rash;
   Voltaren (Oral) (Diclofenac Sodium)
   Unknown;
   Penicillins
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2114-11-4**] 12:00 AM
   Metronidazole - [**2114-11-4**] 01:59 AM
   Meropenem - [**2114-11-4**] 03:00 AM
   Infusions:
   Heparin Sodium - 800 units/hour
   Other ICU medications:
   Furosemide (Lasix) - [**2114-11-3**] 10:00 AM
   Fentanyl - [**2114-11-3**] 12:15 PM
   Midazolam (Versed) - [**2114-11-3**] 12:16 PM
   Metoprolol - [**2114-11-3**] 08:25 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2114-11-4**] 05:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.7
C (101.6
   Tcurrent: 36.9
C (98.5
   HR: 86 (84 - 112) bpm
   BP: 97/47(60) {77/36(47) - 118/72(82)} mmHg
   RR: 24 (16 - 33) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 83.9 kg (admission): 85.6 kg
    CVP: -4 (-4 - 326)mmHg
   Total In:
                                                                  1,439 mL
                                                                    475 mL
   PO:
   TF:
   IVF:
                                                                  1,064 mL
                                                                    475 mL
   Blood products:
                                                                    375 mL
   Total out:
                                                                  2,765 mL
                                                                    560 mL
   Urine:
                                                                  2,765 mL
                                                                    560 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,326 mL
                                                                    -85 mL
   Respiratory support
   O2 Delivery Device: Bipap mask
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 849 (578 - 1,363) mL
   PS : 10 cmH2O
   RR (Spontaneous): 30
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: 7.44/34/69//0
   Ve: 4.4 L/min
   PaO2 / FiO2: 138
   Physical Examination
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: No JVD
   CARDIAC: RRR, with loud S2, crescendo-decrescendo murmur at LUSB
   LUNGS: Diffuse rales in posterior lung fields, obscured by BiPAP
   ABDOMEN: Soft, RLQ TTP.  Voluntary guarding.  No rebound.
   EXTREMITIES: No c/c/e. No femoral bruits.
   Neuro:  Moves all 4 with commands.  [**1-23**] handgrip on R, 0/5 on L.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
                                     144
                               [image002.gif]
                                     111
                               [image002.gif]
                                     22
   [image004.gif]
   133
                                                                   AGap=12
   [image005.gif]
   3.5
                               [image002.gif]
                                     25
                               [image002.gif]
                                     1.2
   [image007.gif]
   Mg: 2.1
   Source: Line-central
   93
                                                                      21.3
                                                            [image007.gif]
                                     8.9
   [image004.gif]
   275
                 [image008.gif]
   [image004.gif]
                                    26.7
   [image007.gif]
   Source: [**Name (NI) 6416**]
   PT: 15.8
   PTT: 65.8
   INR: 1.4
                            [**2114-11-2**]  05:00 PM
                            [**2114-11-2**]  09:28 PM
                            [**2114-11-3**]  03:10 AM
                            [**2114-11-3**]  03:22 PM
                            [**2114-11-3**]  06:17 PM
   WBC
   20.8
   25.0
   Post transfusion
   Hct
   29.3
   25.9
   32
   Plt
   321
   355
   Cr
   1.0
   1.0
   TropT
   0.05
   TCO2
   24
   Glucose
   130
   155
   Other labs: PT / PTT / INR:16.1/58.9/1.4, CK / CKMB /
   Troponin-T:58//0.05, ALT / AST:33/62, Alk Phos / T Bili:99/0.4, Amylase
   / Lipase:49/53, Differential-Neuts:86.5 %, Lymph:7.7 %, Mono:4.6 %,
   Eos:0.9 %, Lactic Acid:2.7 mmol/L, Albumin:2.9 g/dL, LDH:462 IU/L,
   Ca++:8.1 mg/dL, Mg++:2.1 mg/dL, PO4:1.8 mg/dL
   The left atrium is dilated. Mild spontaneous echo contrast is seen in
   the body of the left atrium. Moderate to severe spontaneous echo
   contrast is present in the left atrial appendage. The left atrial
   appendage emptying velocity is depressed (<0.2m/s). A probable thrombus
   is seen in the tip of the left atrial appendage. No atrial septal
   defect is seen by 2D or color Doppler. There are simple atheroma in the
   ascending aorta. There are simple atheroma in the aortic arch. There
   are simple atheroma in the descending thoracic aorta up to 35cm from
   the incisor. The aortic valve leaflets (3) are moderately thickened.
   There is severe aortic valve stenosis (area 0.6cm2 by planimetry).
   Trace aortic regurgitation is seen. [Due to acoustic shadowing, the
   severity of aortic regurgitation may be significantly UNDERestimated.]
   A mechanical mitral valve prosthesis is present. There is extensive
   thrombus around the ring of the prosthesis that measures at least 3.4cm
   by 1.1cm by dimension. There is a highly mobile component of the
   thrombus that measure 1.9cm x 0.5cm that prolapses through the mitral
   valve orifice. The anterior/septal mitral valve leaflet is completely
   immobile. The posterior/lateral leaflet moves well. The gradients
   across the mitral valve is suggestive of severe valvular mitral
   stenosis. A tricuspid valve annuloplasty ring is present with trace
   tricuspid regurgitation. There is no pericardial effusion.
   Impression: Extensive thrombus around the mechanical mitral prosthesis
   causing severe mitral stenosis. Severe aortic stenosis. Thrombus in the
   left atrial appendage.
   CXR: worsening infilterates involving midzones of both lungs suggests
   superimposed
   multifocal pneumonia or unusual pattern of progression of heart
   failure. The
   remainder of the study including the lines and tubes are unchanged.
Sputum: GRAM STAIN (Final [**2114-11-3**]):
      >25 PMNs and <10 epithelial cells/100X field.
      NO MICROORGANISMS SEEN.
   Assessment and Plan
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed
   .
   # Prosthetic Mitral Valve Thrombus:  Echocardiogram consistent with
   thrombus on prosthetic MV valve and fluroscopy shows one leaflet that
   is fixed.  Patient has TTE during admission at [**Hospital1 1817**] three weeks ago
   that was negative for valvular thrombus.  TTE shows gradient pressures
   of Mitral 28/(mean)18 and Aortic 45/(mean)23.  Given the patient had
   recently had a hemorrhagic stroke and recent GI bleed, the management
   will be difficult.  Patient had resumed coumadin on transfer to
   rehabilitation to prevent further clots.  Patient would likely be a
   poor surgical candidate.  This issue represents an end-stage disease
   and this is understood by family.
   - Will continue Heparin gtt
   - Palliative care consult
   - Goal to get home with family, respiratory support and pain control
   .
   # Acute Congestive Heart Failure:  Secondary to Mitral valve thrombus
   and atrial fibrillation.  Patient has high gradient between LA and LV,
   also not filling well secondary to functional stenosis secondary to
   thrombus.   Good response to low-dose IV metoprolol.
   - PO metoprolol 25 mg TID.
   - Bumex 1 mg [**Hospital1 **], which is
 home dose with goal of even
   .
   # GI bleed:  Unclear source, likely lower GI.  HCT dropped from 29 to
   25 this AM and was subsequently transfused.  Hct responded
   appropriately but then came back down.
   - GI recs for endoscopy
   - Transfusion for symptomatic anemia
   .
   # Atrial Fibrillation:  Poorly rate controlled.  Dig level 1.1, likely
   toxic level in this patient in light of her EKG changes.
   - Will start BB
   - Heparin gtt for further thrombus progression
   .
   # CORONARIES:  h/o CAD documented in OSH records, however patient had
   cath in [**2109**] that showed normal coronaries. Pt had STD on EKG possibly
   in setting of GI Bleed/demand or related to digoxin toxicity.
   .
   # PUMP:  Previous TTE at [**Hospital1 1817**] 3 wks ago showed EF of 50% with no
   thrombus, with presence of dilated left atrium.
   - TEE today
   .
   # RLL Pneumonia:  Possible cause of her elevated WBC of 25 this AM.
   Lactate 1.3.  WBC at OSH was elevated.  Afebrile.  Not apparent that
   BCx obtained at OSH.  In context of thrombus, differential includes
   infected thrombus for leukocytosis.  C. diff negatibe
   - BCx and UCx pending
   - Continue Vanco and Meropenem
   - D/C flagyl
   .
   # HTN:  BP 108/43.  SBPs on admission in 80s.
   - Start BB.
   .
   # Hypothyroidism:  Continue home synthroid.
   .
   # s/p hemorrhagic stroke:  Patient with neurological deficits on exam.
   Patient at risk for further embolic event with thrombus.
   .
   FEN: Low salt, thickened liquids, advance to full
   ACCESS: 18 gauge PIV and R IJ
   PROPHYLAXIS:
   -DVT ppx with Hep gtt, IV PPI
   CODE: Full Code.  Will need to be readdressed with family.
   DISPO: CCU for now
   . IV access: Temporary central access (ICU) Location: Right Internal
   Jugular, Date inserted: [**2114-11-3**] Order date: [**11-3**] @ 0903
   16. Lidocaine Viscous 2% 20 ml PO ONCE Duration: 1 Doses Order date:
   [**11-3**] @ 1139
   2. Acetaminophen 650 mg PO ONCE Duration: 1 Doses Order date: [**11-3**] @
   0903
   17. Metoprolol Tartrate 5 mg IV ONCE Duration: 1 Doses Order date:
   [**11-3**] @ 0903
   3. Acetaminophen 650 mg PO ONCE Duration: 1 Doses Order date: [**11-3**] @
   2106
   18. MetRONIDAZOLE (FLagyl) 500 mg IV Q8H
   Start [**11-3**]  Order date: [**11-3**] @ 0914
   4. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN  Order date: [**11-3**] @ 1542
   19. Meropenem 500 mg IV Q6H Duration: 48 Hours Order date: [**11-3**] @ 1846
   5. BuPROPion (Sustained Release) 150 mg PO QAM  Order date: [**11-2**] @
   2053
   20. Metoprolol Tartrate 5 mg IV ONCE Duration: 1 Doses Order date:
   [**11-3**] @ [**2032**]
   6. Bumetanide 1 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 2244
   21. Midazolam 1 mg IV PRN  Order date: [**11-3**] @ 1139
   7. Fentanyl Citrate 25-100 mcg IV PRN  Order date: [**11-3**] @ 1138
   22. Ondansetron 4 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 0800
   8. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH [**Hospital1 **]  Order date:
   [**11-2**] @ [**2015**]
   23. Paroxetine 30 mg PO DAILY  Order date: [**11-2**] @ 2053
   9. Furosemide 40 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 0903
   24. Pantoprazole 40 mg IV Q12H  Order date: [**11-3**] @ 1300
   10. Gabapentin 300 mg PO TID  Order date: [**11-2**] @ 2053
   25. Pneumococcal Vac Polyvalent 0.5 ml IM ASDIR  Order date: [**11-2**] @
   [**2010**]
   11. Heparin IV per Weight-Based Dosing Guidelines
   Order date: [**11-2**] @ [**2008**]
   26. Potassium Chloride 40 mEq / 100 ml SW IV ONCE Duration: 1 Doses
   Order date: [**11-3**] @ 1543
   12. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**11-2**] @ [**2010**]
   27. Simvastatin 40 mg PO DAILY  Order date: [**11-2**] @ 2053
   13. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale Order date: [**11-2**] @ [**2014**]
   28. Sodium Chloride 0.9% Flush 10 mL IV PRN line flush
   Temporary Central Access-ICU: Flush with 10mL Normal Saline daily and
   PRN.  Order date: [**11-3**] @ 0903
   14. Ipratropium Bromide Neb 1 NEB IH Q6H PRN  Order date: [**11-3**] @ 1542
   29. Vancomycin 1000 mg IV Q 12H
   ID Approval will be required for this order in 51 hours.  Order date:
   [**11-3**] @ 0445
   15. Levothyroxine Sodium 25 mcg PO DAILY  Order date: [**11-2**] @ [**2010**]
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2114-11-3**] 12:15 PM
 NON-INVASIVE VENTILATION - START [**2114-11-3**] 06:27 PM
 EKG - At [**2114-11-3**] 08:00 PM
 FEVER - 101.6
F - [**2114-11-3**] 10:00 PM
   TEE showed thrombus increasing in size.  Family meeting: plan not to
   escalate care.  Would make CMO if worsening.  GI recommended CT scan
   when more stable and following lactate.  Tachycardia responded well to
   5 mg metoprolol bolus in AM and PM.  Hypoxic -> ABG, CXR, CPAP o/n.
   Fevers through vanc/[**Last Name (un) 430**].
   Tele: HR improved with metoprolol.  Desats at 11 PM.  Prior to CPAP.
   Allergies:
   Lasix (Oral) (Furosemide)
   Hives;
   Codeine
   Rash;
   Ceclor (Oral) (Cefaclor)
   Unknown;
   Keflex (Oral) (Cephalexin Monohydrate)
   Rash;
   Voltaren (Oral) (Diclofenac Sodium)
   Unknown;
   Penicillins
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2114-11-4**] 12:00 AM
   Metronidazole - [**2114-11-4**] 01:59 AM
   Meropenem - [**2114-11-4**] 03:00 AM
   Infusions:
   Heparin Sodium - 800 units/hour
   Other ICU medications:
   Furosemide (Lasix) - [**2114-11-3**] 10:00 AM
   Fentanyl - [**2114-11-3**] 12:15 PM
   Midazolam (Versed) - [**2114-11-3**] 12:16 PM
   Metoprolol - [**2114-11-3**] 08:25 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2114-11-4**] 05:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.7
C (101.6
   Tcurrent: 36.9
C (98.5
   HR: 86 (84 - 112) bpm
   BP: 97/47(60) {77/36(47) - 118/72(82)} mmHg
   RR: 24 (16 - 33) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 83.9 kg (admission): 85.6 kg
    CVP: -4 (-4 - 326)mmHg
   Total In:
                                                                  1,439 mL
                                                                    475 mL
   PO:
   TF:
   IVF:
                                                                  1,064 mL
                                                                    475 mL
   Blood products:
                                                                    375 mL
   Total out:
                                                                  2,765 mL
                                                                    560 mL
   Urine:
                                                                  2,765 mL
                                                                    560 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,326 mL
                                                                    -85 mL
   Respiratory support
   O2 Delivery Device: Bipap mask
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 849 (578 - 1,363) mL
   PS : 10 cmH2O
   RR (Spontaneous): 30
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: 7.44/34/69//0
   Ve: 4.4 L/min
   PaO2 / FiO2: 138
   Physical Examination
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: No JVD
   CARDIAC: RRR, with loud S2, crescendo-decrescendo murmur at LUSB
   LUNGS: Diffuse rales in posterior lung fields, obscured by BiPAP
   ABDOMEN: Soft, RLQ TTP.  Voluntary guarding.  No rebound.
   EXTREMITIES: No c/c/e. No femoral bruits.
   Neuro:  Moves all 4 with commands.  [**1-23**] handgrip on R, 0/5 on L.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
                                     144
                               [image002.gif]
                                     111
                               [image002.gif]
                                     22
   [image004.gif]
   133
                                                                   AGap=12
   [image005.gif]
   3.5
                               [image002.gif]
                                     25
                               [image002.gif]
                                     1.2
   [image007.gif]
   Mg: 2.1
   Source: Line-central
   93
                                                                      21.3
                                                            [image007.gif]
                                     8.9
   [image004.gif]
   275
                 [image008.gif]
   [image004.gif]
                                    26.7
   [image007.gif]
   Source: [**Name (NI) 6416**]
   PT: 15.8
   PTT: 65.8
   INR: 1.4
                            [**2114-11-2**]  05:00 PM
                            [**2114-11-2**]  09:28 PM
                            [**2114-11-3**]  03:10 AM
                            [**2114-11-3**]  03:22 PM
                            [**2114-11-3**]  06:17 PM
   WBC
   20.8
   25.0
   Post transfusion
   Hct
   29.3
   25.9
   32
   Plt
   321
   355
   Cr
   1.0
   1.0
   TropT
   0.05
   TCO2
   24
   Glucose
   130
   155
   Other labs: PT / PTT / INR:16.1/58.9/1.4, CK / CKMB /
   Troponin-T:58//0.05, ALT / AST:33/62, Alk Phos / T Bili:99/0.4, Amylase
   / Lipase:49/53, Differential-Neuts:86.5 %, Lymph:7.7 %, Mono:4.6 %,
   Eos:0.9 %, Lactic Acid:2.7 mmol/L, Albumin:2.9 g/dL, LDH:462 IU/L,
   Ca++:8.1 mg/dL, Mg++:2.1 mg/dL, PO4:1.8 mg/dL
   The left atrium is dilated. Mild spontaneous echo contrast is seen in
   the body of the left atrium. Moderate to severe spontaneous echo
   contrast is present in the left atrial appendage. The left atrial
   appendage emptying velocity is depressed (<0.2m/s). A probable thrombus
   is seen in the tip of the left atrial appendage. No atrial septal
   defect is seen by 2D or color Doppler. There are simple atheroma in the
   ascending aorta. There are simple atheroma in the aortic arch. There
   are simple atheroma in the descending thoracic aorta up to 35cm from
   the incisor. The aortic valve leaflets (3) are moderately thickened.
   There is severe aortic valve stenosis (area 0.6cm2 by planimetry).
   Trace aortic regurgitation is seen. [Due to acoustic shadowing, the
   severity of aortic regurgitation may be significantly UNDERestimated.]
   A mechanical mitral valve prosthesis is present. There is extensive
   thrombus around the ring of the prosthesis that measures at least 3.4cm
   by 1.1cm by dimension. There is a highly mobile component of the
   thrombus that measure 1.9cm x 0.5cm that prolapses through the mitral
   valve orifice. The anterior/septal mitral valve leaflet is completely
   immobile. The posterior/lateral leaflet moves well. The gradients
   across the mitral valve is suggestive of severe valvular mitral
   stenosis. A tricuspid valve annuloplasty ring is present with trace
   tricuspid regurgitation. There is no pericardial effusion.
   Impression: Extensive thrombus around the mechanical mitral prosthesis
   causing severe mitral stenosis. Severe aortic stenosis. Thrombus in the
   left atrial appendage.
   CXR: worsening infilterates involving midzones of both lungs suggests
   superimposed
   multifocal pneumonia or unusual pattern of progression of heart
   failure. The
   remainder of the study including the lines and tubes are unchanged.
Sputum: GRAM STAIN (Final [**2114-11-3**]):
      >25 PMNs and <10 epithelial cells/100X field.
      NO MICROORGANISMS SEEN.
   Assessment and Plan
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed
   .
   # Prosthetic Mitral Valve Thrombus:  Echocardiogram consistent with
   thrombus on prosthetic MV valve and fluroscopy shows one leaflet that
   is fixed.  Patient has TTE during admission at [**Hospital1 1817**] three weeks ago
   that was negative for valvular thrombus.  TTE shows gradient pressures
   of Mitral 28/(mean)18 and Aortic 45/(mean)23.  Given the patient had
   recently had a hemorrhagic stroke and recent GI bleed, the management
   will be difficult.  Patient had resumed coumadin on transfer to
   rehabilitation to prevent further clots.  Patient would likely be a
   poor surgical candidate.  This issue represents an end-stage disease
   and this is understood by family.
   - Will continue Heparin gtt
   - Palliative care consult
   - Goal to get home with family, respiratory support and pain control
   .
   # Acute Congestive Heart Failure:  Secondary to Mitral valve thrombus
   and atrial fibrillation.  Patient has high gradient between LA and LV,
   also not filling well secondary to functional stenosis secondary to
   thrombus.   Good response to low-dose IV metoprolol.
   - PO metoprolol 25 mg TID.
   - Bumex 1 mg [**Hospital1 **], which is
 home dose with goal of even
   .
   # GI bleed:  Unclear source, likely lower GI.  HCT dropped from 29 to
   25 this AM and was subsequently transfused.  Hct responded
   appropriately but then came back down.
   - GI recs for endoscopy
   - Transfusion for symptomatic anemia
   .
   # Atrial Fibrillation:  Poorly rate controlled.  Dig level 1.1, likely
   toxic level in this patient in light of her EKG changes.
   - Will start BB
   - Heparin gtt for further thrombus progression
   .
   # CORONARIES:  h/o CAD documented in OSH records, however patient had
   cath in [**2109**] that showed normal coronaries. Pt had STD on EKG possibly
   in setting of GI Bleed/demand or related to digoxin toxicity.
   .
   # PUMP:  Previous TTE at [**Hospital1 1817**] 3 wks ago showed EF of 50% with no
   thrombus, with presence of dilated left atrium.
   - TEE today
   .
   # RLL Pneumonia:  Possible cause of her elevated WBC of 25 this AM.
   Lactate 1.3.  WBC at OSH was elevated.  Afebrile.  Not apparent that
   BCx obtained at OSH.  In context of thrombus, differential includes
   infected thrombus for leukocytosis.  C. diff negatibe
   - BCx and UCx pending
   - Continue Vanco and Meropenem
   - D/C flagyl
   .
   # HTN:  BP 108/43.  SBPs on admission in 80s.
   - Start BB.
   .
   # Hypothyroidism:  Continue home synthroid.
   .
   # s/p hemorrhagic stroke:  Patient with neurological deficits on exam.
   Patient at risk for further embolic event with thrombus.
   .
   FEN: Low salt, thickened liquids, advance to full
   ACCESS: 18 gauge PIV and R IJ
   PROPHYLAXIS:
   -DVT ppx with Hep gtt, IV PPI
   CODE: Full Code.  Will need to be readdressed with family.
   DISPO: CCU for now
   . IV access: Temporary central access (ICU) Location: Right Internal
   Jugular, Date inserted: [**2114-11-3**] Order date: [**11-3**] @ 0903
   16. Lidocaine Viscous 2% 20 ml PO ONCE Duration: 1 Doses Order date:
   [**11-3**] @ 1139
   2. Acetaminophen 650 mg PO ONCE Duration: 1 Doses Order date: [**11-3**] @
   0903
   17. Metoprolol Tartrate 5 mg IV ONCE Duration: 1 Doses Order date:
   [**11-3**] @ 0903
   3. Acetaminophen 650 mg PO ONCE Duration: 1 Doses Order date: [**11-3**] @
   2106
   18. MetRONIDAZOLE (FLagyl) 500 mg IV Q8H
   Start [**11-3**]  Order date: [**11-3**] @ 0914
   4. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN  Order date: [**11-3**] @ 1542
   19. Meropenem 500 mg IV Q6H Duration: 48 Hours Order date: [**11-3**] @ 1846
   5. BuPROPion (Sustained Release) 150 mg PO QAM  Order date: [**11-2**] @
   2053
   20. Metoprolol Tartrate 5 mg IV ONCE Duration: 1 Doses Order date:
   [**11-3**] @ [**2032**]
   6. Bumetanide 1 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 2244
   21. Midazolam 1 mg IV PRN  Order date: [**11-3**] @ 1139
   7. Fentanyl Citrate 25-100 mcg IV PRN  Order date: [**11-3**] @ 1138
   22. Ondansetron 4 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 0800
   8. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH [**Hospital1 **]  Order date:
   [**11-2**] @ [**2015**]
   23. Paroxetine 30 mg PO DAILY  Order date: [**11-2**] @ 2053
   9. Furosemide 40 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 0903
   24. Pantoprazole 40 mg IV Q12H  Order date: [**11-3**] @ 1300
   10. Gabapentin 300 mg PO TID  Order date: [**11-2**] @ 2053
   25. Pneumococcal Vac Polyvalent 0.5 ml IM ASDIR  Order date: [**11-2**] @
   [**2010**]
   11. Heparin IV per Weight-Based Dosing Guidelines
   Order date: [**11-2**] @ [**2008**]
   26. Potassium Chloride 40 mEq / 100 ml SW IV ONCE Duration: 1 Doses
   Order date: [**11-3**] @ 1543
   12. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**11-2**] @ [**2010**]
   27. Simvastatin 40 mg PO DAILY  Order date: [**11-2**] @ 2053
   13. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale Order date: [**11-2**] @ [**2014**]
   28. Sodium Chloride 0.9% Flush 10 mL IV PRN line flush
   Temporary Central Access-ICU: Flush with 10mL Normal Saline daily and
   PRN.  Order date: [**11-3**] @ 0903
   14. Ipratropium Bromide Neb 1 NEB IH Q6H PRN  Order date: [**11-3**] @ 1542
   29. Vancomycin 1000 mg IV Q 12H
   ID Approval will be required for this order in 51 hours.  Order date:
   [**11-3**] @ 0445
   15. Levothyroxine Sodium 25 mcg PO DAILY  Order date: [**11-2**] @ [**2010**]<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided medical progress note, I summarize the patient's health progress as follows:

The patient is a 66-year-old female who has been admitted to the ICU with a history of CVA with hemorrhagic evolution, AV and MV valve transfer, and a recent GI bleed. The patient has a prosthetic mitral valve with thrombus formation, which is causing severe mitral stenosis. She also has atrial fibrillation, which is poorly rate-controlled.

The patient's vital signs are stable, with a heart rate of 86 bpm, blood pressure of 97/47 mmHg, respiratory rate of 24 breaths per minute, and oxygen saturation of 99%. Her temperature is 101.6°F (38.7°C).

The patient has a history of CAD, but a recent catheterization showed normal coronary arteries. She has also had a TTE (transesophageal echocardiogram) in the past, which showed an EF of 50% with no thrombus.

The patient's lab results show elevated WBC count, lactate level, and troponin-T level. Her electrolytes are within normal limits, but her INR is slightly elevated.

The patient's physical examination reveals a dilated left atrium, mild spontaneous echo contrast in the body of the left atrium, and moderate to severe spontaneous echo contrast in the left atrial appendage. The patient has a mechanical mitral valve prosthesis with extensive thrombus formation around the ring, causing severe mitral stenosis.

The patient's diagnosis includes prosthetic mitral valve thrombus, acute congestive heart failure, GI bleed, atrial fibrillation, and RLL pneumonia.

Potential medical complications that may arise from the patient's condition include:

1. Further embolic events due to the thrombus in the left atrial appendage.
2. Worsening of the patient's congestive heart failure due to the severe mitral stenosis.
3. Development of pneumonia due to the RLL infiltrates.
4. GI bleeding due to the patient's history of GI bleeding.
5. Atrial fibrillation may lead to further complications such as stroke or heart failure.
6. The patient's poor response to anticoagulation therapy may lead to further thrombus formation.

Based on the patient's condition, the following plan has been implemented:

1. Continue Heparin gtt to prevent further thrombus formation.
2. Palliative care consult to discuss end-of-life care options with the patient and her family.
3. Goal to get the patient home with family, respiratory support, and pain control.
4. Continue IV metoprolol to control the patient's heart rate.
5. Bumex 1 mg IV to control the patient's blood pressure.
6. GI recs for endoscopy to evaluate the source of the patient's GI bleed.
7. Transfusion for symptomatic anemia.
8. Continue antibiotics for pneumonia.
9. Monitor the patient's electrolytes and INR levels closely.

Overall, the patient's condition is complex and requires close monitoring and management to prevent further complications."
139476.0,203250,2114-11-04 05:42:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2114-11-3**] 12:15 PM
 NON-INVASIVE VENTILATION - START [**2114-11-3**] 06:27 PM
 EKG - At [**2114-11-3**] 08:00 PM
 FEVER - 101.6
F - [**2114-11-3**] 10:00 PM
   TEE showed thrombus increasing in size.  Family meeting: plan not to
   escalate care.  Would make CMO if worsening.  GI recommended CT scan
   when more stable and following lactate.  Tachycardia responded well to
   5 mg metoprolol bolus in AM and PM.  Hypoxic -> ABG, CXR, CPAP o/n.
   Fevers through vanc/[**Last Name (un) 430**].
   Allergies:
   Lasix (Oral) (Furosemide)
   Hives;
   Codeine
   Rash;
   Ceclor (Oral) (Cefaclor)
   Unknown;
   Keflex (Oral) (Cephalexin Monohydrate)
   Rash;
   Voltaren (Oral) (Diclofenac Sodium)
   Unknown;
   Penicillins
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2114-11-4**] 12:00 AM
   Metronidazole - [**2114-11-4**] 01:59 AM
   Meropenem - [**2114-11-4**] 03:00 AM
   Infusions:
   Heparin Sodium - 800 units/hour
   Other ICU medications:
   Furosemide (Lasix) - [**2114-11-3**] 10:00 AM
   Fentanyl - [**2114-11-3**] 12:15 PM
   Midazolam (Versed) - [**2114-11-3**] 12:16 PM
   Metoprolol - [**2114-11-3**] 08:25 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2114-11-4**] 05:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.7
C (101.6
   Tcurrent: 36.9
C (98.5
   HR: 86 (84 - 112) bpm
   BP: 97/47(60) {77/36(47) - 118/72(82)} mmHg
   RR: 24 (16 - 33) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 83.9 kg (admission): 85.6 kg
    CVP: -4 (-4 - 326)mmHg
   Total In:
                                                                  1,439 mL
                                                                    475 mL
   PO:
   TF:
   IVF:
                                                                  1,064 mL
                                                                    475 mL
   Blood products:
                                                                    375 mL
   Total out:
                                                                  2,765 mL
                                                                    560 mL
   Urine:
                                                                  2,765 mL
                                                                    560 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,326 mL
                                                                    -85 mL
   Respiratory support
   O2 Delivery Device: Bipap mask
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 849 (578 - 1,363) mL
   PS : 10 cmH2O
   RR (Spontaneous): 30
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: 7.44/34/69//0
   Ve: 4.4 L/min
   PaO2 / FiO2: 138
   Physical Examination
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: No JVD
   CARDIAC: RRR, with loud S2, crescendo-decrescendo murmur at LUSB
   LUNGS: Diffuse rales in posterior lung fields
   ABDOMEN: Soft, RLQ TTP.  Voluntary guarding.  No rebound.
   EXTREMITIES: No c/c/e. No femoral bruits.
   Neuro:  CN II-XII intact, with following exceptions. [**2-21**] Plantar
   flexion of L and R LE.  [**3-24**] handgrip on R, [**1-23**] on L.  Absent L sided
   startle reflex, L lid lag and facial droop.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   [**2114-11-2**]  05:00 PM
                            [**2114-11-2**]  09:28 PM
                            [**2114-11-3**]  03:10 AM
                            [**2114-11-3**]  03:22 PM
                            [**2114-11-3**]  06:17 PM
   WBC
   20.8
   25.0
   Hct
   29.3
   25.9
   32
   Plt
   321
   355
   Cr
   1.0
   1.0
   TropT
   0.05
   TCO2
   24
   Glucose
   130
   155
   Other labs: PT / PTT / INR:16.1/58.9/1.4, CK / CKMB /
   Troponin-T:58//0.05, ALT / AST:33/62, Alk Phos / T Bili:99/0.4, Amylase
   / Lipase:49/53, Differential-Neuts:86.5 %, Lymph:7.7 %, Mono:4.6 %,
   Eos:0.9 %, Lactic Acid:2.7 mmol/L, Albumin:2.9 g/dL, LDH:462 IU/L,
   Ca++:8.1 mg/dL, Mg++:2.1 mg/dL, PO4:1.8 mg/dL
   The left atrium is dilated. Mild spontaneous echo contrast is seen in
   the body of the left atrium. Moderate to severe spontaneous echo
   contrast is present in the left atrial appendage. The left atrial
   appendage emptying velocity is depressed (<0.2m/s). A probable thrombus
   is seen in the tip of the left atrial appendage. No atrial septal
   defect is seen by 2D or color Doppler. There are simple atheroma in the
   ascending aorta. There are simple atheroma in the aortic arch. There
   are simple atheroma in the descending thoracic aorta up to 35cm from
   the incisor. The aortic valve leaflets (3) are moderately thickened.
   There is severe aortic valve stenosis (area 0.6cm2 by planimetry).
   Trace aortic regurgitation is seen. [Due to acoustic shadowing, the
   severity of aortic regurgitation may be significantly UNDERestimated.]
   A mechanical mitral valve prosthesis is present. There is extensive
   thrombus around the ring of the prosthesis that measures at least 3.4cm
   by 1.1cm by dimension. There is a highly mobile component of the
   thrombus that measure 1.9cm x 0.5cm that prolapses through the mitral
   valve orifice. The anterior/septal mitral valve leaflet is completely
   immobile. The posterior/lateral leaflet moves well. The gradients
   across the mitral valve is suggestive of severe valvular mitral
   stenosis. A tricuspid valve annuloplasty ring is present with trace
   tricuspid regurgitation. There is no pericardial effusion.
   Impression: Extensive thrombus around the mechanical mitral prosthesis
   causing severe mitral stenosis. Severe aortic stenosis. Thrombus in the
   left atrial appendage.
   CXR: worsening infilterates involving midzones of both lungs suggests
   superimposed
   multifocal pneumonia or unusual pattern of progression of heart
   failure. The
   remainder of the study including the lines and tubes are unchanged.
Sputum: GRAM STAIN (Final [**2114-11-3**]):
      >25 PMNs and <10 epithelial cells/100X field.
      NO MICROORGANISMS SEEN.
   Assessment and Plan
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed
   .
   # Acute Congestive Heart Failure:  Secondary to Mitral valve thrombus
   and atrial fibrillation.  Patient has high gradient between LA and LV,
   also not filling well secondary to functional stenosis secondary to
   thrombus.
   -          Start low dose Metoprolol IV for HR control to help forward
   flow.
   -          Lasix prn
   Prosthetic Mitral Valve Thrombus:  Echocardiogram consistent with
   thrombus on prosthetic MV valve and fluroscopy shows one leaflet that
   is fixed.  Patient has TTE during admission at [**Hospital1 1817**] three weeks ago
   that was negative for valvular thrombus.  TTE shows gradient pressures
   of Mitral 28/(mean)18 and Aortic 45/(mean)23.  Given the patient had
   recently had a hemorrhagic stroke and recent GI bleed, the management
   will be difficult.  Patient had resumed coumadin on transfer to
   rehabilitation to prevent further clots.  Need to have dialogue with
   surgery if she will be candidate for surgery in the future.
   - Will continue Heparin gtt
   - TEE today
   # GI bleed:  Unclear source, likely lower GI.  HCT dropped from 29 to
   25 this AM and was subsequently transfused
   - GI recs for endoscopy
   - Will transfuse as needed
   - Trend HCT
   # Atrial Fibrillation:  Poorly rate controlled.  Dig level 1.1, likely
   toxic level in this patient in light of her EKG changes.
   - Will start BB
   - Heparin gtt for further thrombus progression
   # CORONARIES:  h/o CAD documented in OSH records, however patient had
   cath in [**2109**] that showed normal coronaries. Pt had STD on EKG possibly
   in setting of GI Bleed/demand or related to digoxin toxicity.
   .
   # PUMP:  Previous TTE at [**Hospital1 1817**] 3 wks ago showed EF of 50% with no
   thrombus, with presence of dilated left atrium.
   - TEE today
   .
   # RLL Pneumonia:  Possible cause of her elevated WBC of 25 this AM.
   Lactate 1.3.  WBC at OSH was elevated.  Afebrile.  Not apparent that
   BCx obtained at OSH.  In context of thrombus, differential includes
   infected thrombus for leukocytosis.
   - BCx and UCx pending
   - Continue Vanco and Meropenem
   - Check CDiff, start IV Flagyl
   .
   # HTN:  BP 108/43.  SBPs on admission in 80s.
   - Start BB.
   .
   # Hypothyroidism:  Continue home synthroid.
   .
   # s/p hemorrhagic stroke:  Patient with neurological deficits on exam.
   Patient at risk for further embolic event with thrombus.
   .
   FEN: Low salt, thickened liquids
   ACCESS: 18 gauge PIV and R IJ
   PROPHYLAXIS:
   -DVT ppx with Hep gtt, IV PPI
   CODE: Full Code.  Will need to be readdressed with family.
   DISPO: CCU for now
   .
   . IV access: Temporary central access (ICU) Location: Right Internal
   Jugular, Date inserted: [**2114-11-3**] Order date: [**11-3**] @ 0903
   16. Lidocaine Viscous 2% 20 ml PO ONCE Duration: 1 Doses Order date:
   [**11-3**] @ 1139
   2. Acetaminophen 650 mg PO ONCE Duration: 1 Doses Order date: [**11-3**] @
   0903
   17. Metoprolol Tartrate 5 mg IV ONCE Duration: 1 Doses Order date:
   [**11-3**] @ 0903
   3. Acetaminophen 650 mg PO ONCE Duration: 1 Doses Order date: [**11-3**] @
   2106
   18. MetRONIDAZOLE (FLagyl) 500 mg IV Q8H
   Start [**11-3**]  Order date: [**11-3**] @ 0914
   4. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN  Order date: [**11-3**] @ 1542
   19. Meropenem 500 mg IV Q6H Duration: 48 Hours Order date: [**11-3**] @ 1846
   5. BuPROPion (Sustained Release) 150 mg PO QAM  Order date: [**11-2**] @
   2053
   20. Metoprolol Tartrate 5 mg IV ONCE Duration: 1 Doses Order date:
   [**11-3**] @ [**2032**]
   6. Bumetanide 1 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 2244
   21. Midazolam 1 mg IV PRN  Order date: [**11-3**] @ 1139
   7. Fentanyl Citrate 25-100 mcg IV PRN  Order date: [**11-3**] @ 1138
   22. Ondansetron 4 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 0800
   8. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH [**Hospital1 **]  Order date:
   [**11-2**] @ [**2015**]
   23. Paroxetine 30 mg PO DAILY  Order date: [**11-2**] @ 2053
   9. Furosemide 40 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 0903
   24. Pantoprazole 40 mg IV Q12H  Order date: [**11-3**] @ 1300
   10. Gabapentin 300 mg PO TID  Order date: [**11-2**] @ 2053
   25. Pneumococcal Vac Polyvalent 0.5 ml IM ASDIR  Order date: [**11-2**] @
   [**2010**]
   11. Heparin IV per Weight-Based Dosing Guidelines
   Order date: [**11-2**] @ [**2008**]
   26. Potassium Chloride 40 mEq / 100 ml SW IV ONCE Duration: 1 Doses
   Order date: [**11-3**] @ 1543
   12. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**11-2**] @ [**2010**]
   27. Simvastatin 40 mg PO DAILY  Order date: [**11-2**] @ 2053
   13. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale Order date: [**11-2**] @ [**2014**]
   28. Sodium Chloride 0.9% Flush 10 mL IV PRN line flush
   Temporary Central Access-ICU: Flush with 10mL Normal Saline daily and
   PRN.  Order date: [**11-3**] @ 0903
   14. Ipratropium Bromide Neb 1 NEB IH Q6H PRN  Order date: [**11-3**] @ 1542
   29. Vancomycin 1000 mg IV Q 12H
   ID Approval will be required for this order in 51 hours.  Order date:
   [**11-3**] @ 0445
   15. Levothyroxine Sodium 25 mcg PO DAILY  Order date: [**11-2**] @ [**2010**]
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2114-11-3**] 12:15 PM
 NON-INVASIVE VENTILATION - START [**2114-11-3**] 06:27 PM
 EKG - At [**2114-11-3**] 08:00 PM
 FEVER - 101.6
F - [**2114-11-3**] 10:00 PM
   TEE showed thrombus increasing in size.  Family meeting: plan not to
   escalate care.  Would make CMO if worsening.  GI recommended CT scan
   when more stable and following lactate.  Tachycardia responded well to
   5 mg metoprolol bolus in AM and PM.  Hypoxic -> ABG, CXR, CPAP o/n.
   Fevers through vanc/[**Last Name (un) 430**].
   Allergies:
   Lasix (Oral) (Furosemide)
   Hives;
   Codeine
   Rash;
   Ceclor (Oral) (Cefaclor)
   Unknown;
   Keflex (Oral) (Cephalexin Monohydrate)
   Rash;
   Voltaren (Oral) (Diclofenac Sodium)
   Unknown;
   Penicillins
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2114-11-4**] 12:00 AM
   Metronidazole - [**2114-11-4**] 01:59 AM
   Meropenem - [**2114-11-4**] 03:00 AM
   Infusions:
   Heparin Sodium - 800 units/hour
   Other ICU medications:
   Furosemide (Lasix) - [**2114-11-3**] 10:00 AM
   Fentanyl - [**2114-11-3**] 12:15 PM
   Midazolam (Versed) - [**2114-11-3**] 12:16 PM
   Metoprolol - [**2114-11-3**] 08:25 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2114-11-4**] 05:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.7
C (101.6
   Tcurrent: 36.9
C (98.5
   HR: 86 (84 - 112) bpm
   BP: 97/47(60) {77/36(47) - 118/72(82)} mmHg
   RR: 24 (16 - 33) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 83.9 kg (admission): 85.6 kg
    CVP: -4 (-4 - 326)mmHg
   Total In:
                                                                  1,439 mL
                                                                    475 mL
   PO:
   TF:
   IVF:
                                                                  1,064 mL
                                                                    475 mL
   Blood products:
                                                                    375 mL
   Total out:
                                                                  2,765 mL
                                                                    560 mL
   Urine:
                                                                  2,765 mL
                                                                    560 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,326 mL
                                                                    -85 mL
   Respiratory support
   O2 Delivery Device: Bipap mask
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 849 (578 - 1,363) mL
   PS : 10 cmH2O
   RR (Spontaneous): 30
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: 7.44/34/69//0
   Ve: 4.4 L/min
   PaO2 / FiO2: 138
   Physical Examination
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: No JVD
   CARDIAC: RRR, with loud S2, crescendo-decrescendo murmur at LUSB
   LUNGS: Diffuse rales in posterior lung fields
   ABDOMEN: Soft, RLQ TTP.  Voluntary guarding.  No rebound.
   EXTREMITIES: No c/c/e. No femoral bruits.
   Neuro:  CN II-XII intact, with following exceptions. [**2-21**] Plantar
   flexion of L and R LE.  [**3-24**] handgrip on R, [**1-23**] on L.  Absent L sided
   startle reflex, L lid lag and facial droop.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   [**2114-11-2**]  05:00 PM
                            [**2114-11-2**]  09:28 PM
                            [**2114-11-3**]  03:10 AM
                            [**2114-11-3**]  03:22 PM
                            [**2114-11-3**]  06:17 PM
   WBC
   20.8
   25.0
   Hct
   29.3
   25.9
   32
   Plt
   321
   355
   Cr
   1.0
   1.0
   TropT
   0.05
   TCO2
   24
   Glucose
   130
   155
   Other labs: PT / PTT / INR:16.1/58.9/1.4, CK / CKMB /
   Troponin-T:58//0.05, ALT / AST:33/62, Alk Phos / T Bili:99/0.4, Amylase
   / Lipase:49/53, Differential-Neuts:86.5 %, Lymph:7.7 %, Mono:4.6 %,
   Eos:0.9 %, Lactic Acid:2.7 mmol/L, Albumin:2.9 g/dL, LDH:462 IU/L,
   Ca++:8.1 mg/dL, Mg++:2.1 mg/dL, PO4:1.8 mg/dL
   The left atrium is dilated. Mild spontaneous echo contrast is seen in
   the body of the left atrium. Moderate to severe spontaneous echo
   contrast is present in the left atrial appendage. The left atrial
   appendage emptying velocity is depressed (<0.2m/s). A probable thrombus
   is seen in the tip of the left atrial appendage. No atrial septal
   defect is seen by 2D or color Doppler. There are simple atheroma in the
   ascending aorta. There are simple atheroma in the aortic arch. There
   are simple atheroma in the descending thoracic aorta up to 35cm from
   the incisor. The aortic valve leaflets (3) are moderately thickened.
   There is severe aortic valve stenosis (area 0.6cm2 by planimetry).
   Trace aortic regurgitation is seen. [Due to acoustic shadowing, the
   severity of aortic regurgitation may be significantly UNDERestimated.]
   A mechanical mitral valve prosthesis is present. There is extensive
   thrombus around the ring of the prosthesis that measures at least 3.4cm
   by 1.1cm by dimension. There is a highly mobile component of the
   thrombus that measure 1.9cm x 0.5cm that prolapses through the mitral
   valve orifice. The anterior/septal mitral valve leaflet is completely
   immobile. The posterior/lateral leaflet moves well. The gradients
   across the mitral valve is suggestive of severe valvular mitral
   stenosis. A tricuspid valve annuloplasty ring is present with trace
   tricuspid regurgitation. There is no pericardial effusion.
   Impression: Extensive thrombus around the mechanical mitral prosthesis
   causing severe mitral stenosis. Severe aortic stenosis. Thrombus in the
   left atrial appendage.
   CXR: worsening infilterates involving midzones of both lungs suggests
   superimposed
   multifocal pneumonia or unusual pattern of progression of heart
   failure. The
   remainder of the study including the lines and tubes are unchanged.
Sputum: GRAM STAIN (Final [**2114-11-3**]):
      >25 PMNs and <10 epithelial cells/100X field.
      NO MICROORGANISMS SEEN.
   Assessment and Plan
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed
   .
   # Acute Congestive Heart Failure:  Secondary to Mitral valve thrombus
   and atrial fibrillation.  Patient has high gradient between LA and LV,
   also not filling well secondary to functional stenosis secondary to
   thrombus.
   -          Start low dose Metoprolol IV for HR control to help forward
   flow.
   -          Lasix prn
   Prosthetic Mitral Valve Thrombus:  Echocardiogram consistent with
   thrombus on prosthetic MV valve and fluroscopy shows one leaflet that
   is fixed.  Patient has TTE during admission at [**Hospital1 1817**] three weeks ago
   that was negative for valvular thrombus.  TTE shows gradient pressures
   of Mitral 28/(mean)18 and Aortic 45/(mean)23.  Given the patient had
   recently had a hemorrhagic stroke and recent GI bleed, the management
   will be difficult.  Patient had resumed coumadin on transfer to
   rehabilitation to prevent further clots.  Need to have dialogue with
   surgery if she will be candidate for surgery in the future.
   - Will continue Heparin gtt
   - TEE today
   # GI bleed:  Unclear source, likely lower GI.  HCT dropped from 29 to
   25 this AM and was subsequently transfused
   - GI recs for endoscopy
   - Will transfuse as needed
   - Trend HCT
   # Atrial Fibrillation:  Poorly rate controlled.  Dig level 1.1, likely
   toxic level in this patient in light of her EKG changes.
   - Will start BB
   - Heparin gtt for further thrombus progression
   # CORONARIES:  h/o CAD documented in OSH records, however patient had
   cath in [**2109**] that showed normal coronaries. Pt had STD on EKG possibly
   in setting of GI Bleed/demand or related to digoxin toxicity.
   .
   # PUMP:  Previous TTE at [**Hospital1 1817**] 3 wks ago showed EF of 50% with no
   thrombus, with presence of dilated left atrium.
   - TEE today
   .
   # RLL Pneumonia:  Possible cause of her elevated WBC of 25 this AM.
   Lactate 1.3.  WBC at OSH was elevated.  Afebrile.  Not apparent that
   BCx obtained at OSH.  In context of thrombus, differential includes
   infected thrombus for leukocytosis.
   - BCx and UCx pending
   - Continue Vanco and Meropenem
   - Check CDiff, start IV Flagyl
   .
   # HTN:  BP 108/43.  SBPs on admission in 80s.
   - Start BB.
   .
   # Hypothyroidism:  Continue home synthroid.
   .
   # s/p hemorrhagic stroke:  Patient with neurological deficits on exam.
   Patient at risk for further embolic event with thrombus.
   .
   FEN: Low salt, thickened liquids
   ACCESS: 18 gauge PIV and R IJ
   PROPHYLAXIS:
   -DVT ppx with Hep gtt, IV PPI
   CODE: Full Code.  Will need to be readdressed with family.
   DISPO: CCU for now
   .
   . IV access: Temporary central access (ICU) Location: Right Internal
   Jugular, Date inserted: [**2114-11-3**] Order date: [**11-3**] @ 0903
   16. Lidocaine Viscous 2% 20 ml PO ONCE Duration: 1 Doses Order date:
   [**11-3**] @ 1139
   2. Acetaminophen 650 mg PO ONCE Duration: 1 Doses Order date: [**11-3**] @
   0903
   17. Metoprolol Tartrate 5 mg IV ONCE Duration: 1 Doses Order date:
   [**11-3**] @ 0903
   3. Acetaminophen 650 mg PO ONCE Duration: 1 Doses Order date: [**11-3**] @
   2106
   18. MetRONIDAZOLE (FLagyl) 500 mg IV Q8H
   Start [**11-3**]  Order date: [**11-3**] @ 0914
   4. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN  Order date: [**11-3**] @ 1542
   19. Meropenem 500 mg IV Q6H Duration: 48 Hours Order date: [**11-3**] @ 1846
   5. BuPROPion (Sustained Release) 150 mg PO QAM  Order date: [**11-2**] @
   2053
   20. Metoprolol Tartrate 5 mg IV ONCE Duration: 1 Doses Order date:
   [**11-3**] @ [**2032**]
   6. Bumetanide 1 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 2244
   21. Midazolam 1 mg IV PRN  Order date: [**11-3**] @ 1139
   7. Fentanyl Citrate 25-100 mcg IV PRN  Order date: [**11-3**] @ 1138
   22. Ondansetron 4 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 0800
   8. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH [**Hospital1 **]  Order date:
   [**11-2**] @ [**2015**]
   23. Paroxetine 30 mg PO DAILY  Order date: [**11-2**] @ 2053
   9. Furosemide 40 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 0903
   24. Pantoprazole 40 mg IV Q12H  Order date: [**11-3**] @ 1300
   10. Gabapentin 300 mg PO TID  Order date: [**11-2**] @ 2053
   25. Pneumococcal Vac Polyvalent 0.5 ml IM ASDIR  Order date: [**11-2**] @
   [**2010**]
   11. Heparin IV per Weight-Based Dosing Guidelines
   Order date: [**11-2**] @ [**2008**]
   26. Potassium Chloride 40 mEq / 100 ml SW IV ONCE Duration: 1 Doses
   Order date: [**11-3**] @ 1543
   12. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**11-2**] @ [**2010**]
   27. Simvastatin 40 mg PO DAILY  Order date: [**11-2**] @ 2053
   13. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale Order date: [**11-2**] @ [**2014**]
   28. Sodium Chloride 0.9% Flush 10 mL IV PRN line flush
   Temporary Central Access-ICU: Flush with 10mL Normal Saline daily and
   PRN.  Order date: [**11-3**] @ 0903
   14. Ipratropium Bromide Neb 1 NEB IH Q6H PRN  Order date: [**11-3**] @ 1542
   29. Vancomycin 1000 mg IV Q 12H
   ID Approval will be required for this order in 51 hours.  Order date:
   [**11-3**] @ 0445
   15. Levothyroxine Sodium 25 mcg PO DAILY  Order date: [**11-2**] @ [**2010**]<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's current condition as follows:

The patient is a 66-year-old female who was transferred from another hospital with a history of CVA, hemorrhagic evolution, and AV and MV valves. She has a prosthetic mitral valve thrombus, which is causing severe mitral stenosis. She also has severe aortic stenosis and atrial fibrillation, which is poorly rate-controlled. The patient has a history of CAD, but a catheterization performed three weeks ago showed normal coronaries. She has also had a GI bleed, which is unclear in origin, and has been transfused with blood products.

The patient's vital signs are:

* Temperature: 101.6°F (38.7°C)
* Heart rate: 86 bpm (with a range of 84-112 bpm)
* Blood pressure: 97/47 mmHg (with a range of 60-118/36-82 mmHg)
* Respiratory rate: 24 inspirations per minute
* SpO2: 99%

The patient's laboratory results are:

* White blood cell count: 25.0 x 10^9/L
* Hematocrit: 25.9%
* Platelet count: 355 x 10^9/L
* Creatinine: 1.0 mg/dL
* Troponin-T: 0.05 ng/mL
* Lactic acid: 2.7 mmol/L

The patient's echocardiogram shows:

* Extensive thrombus around the mechanical mitral prosthesis causing severe mitral stenosis
* Severe aortic stenosis
* Thrombus in the left atrial appendage

The patient's CXR shows worsening infiltrates involving the midzones of both lungs, suggesting superimposed multifocal pneumonia or an unusual pattern of progression of heart failure.

Potential medical complications that can arise from the patient's condition include:

* Further embolic events due to the thrombus in the left atrial appendage
* Worsening heart failure due to the severe mitral stenosis and aortic stenosis
* Infection of the thrombus, which could lead to sepsis and organ dysfunction
* Gastrointestinal bleeding due to the unclear origin of the patient's recent GI bleed
* Respiratory failure due to the patient's respiratory rate and oxygen saturation

Based on the patient's condition, the following plan has been put in place:

* Start low-dose metoprolol IV for heart rate control to help forward flow
* Continue heparin gtt to prevent further thrombus progression
* Order a TEE to assess the thrombus and mitral valve function
* Continue vancomycin and meropenem for suspected pneumonia
* Check for Clostridium difficile and start IV Flagyl if positive
* Start a beta blocker for atrial fibrillation
* Continue to monitor the patient's blood pressure, heart rate, and oxygen saturation closely."
139476.0,203250,2114-11-05 07:41:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed
   24 Hour Events:
   Heparin d/c
ed.  Patient made DNR/DNI, family considering CMO if
   patient worsens.
   Allergies:
   Lasix (Oral) (Furosemide)
   Hives;
   Codeine
   Rash;
   Ceclor (Oral) (Cefaclor)
   Unknown;
   Keflex (Oral) (Cephalexin Monohydrate)
   Rash;
   Voltaren (Oral) (Diclofenac Sodium)
   Unknown;
   Penicillins
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2114-11-4**] 01:59 AM
   Vancomycin - [**2114-11-5**] 12:00 AM
   Meropenem - [**2114-11-5**] 02:00 AM
   I
   Other ICU medications:
   Morphine Sulfate - [**2114-11-4**] 04:29 PM
   Other medications:
   SSI
   Simvastatin 40mg
   Buproprion 150mg
   Paroxetene 30mg
   Gabapentin 300mg TID
   Fluticasone/Salmertol discus
   Levothyroxine 25mcg
   Vancomycin 1g q12hrs
   Pantoprazole 40mg q12hrs
   Meropenem IV q6hrs x 48hts
   Digoxin 0.125mg daily
   Bumetanide 1mg [**Hospital1 **]
   Lopressor 25mg TID
   Clonazepam 0.5mg TID
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2114-11-5**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.2
C (100.7
   Tcurrent: 36.9
C (98.5
   HR: 88 (80 - 109) bpm
   BP: 86/49(55) {79/36(48) - 106/63(72)} mmHg
   RR: 23 (23 - 33) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 83.9 kg (admission): 85.6 kg
    CVP: 9 (-5 - 222)mmHg
   Total In:
                                                                  2,702 mL
                                                                    436 mL
   PO:
                                                                    950 mL
                                                                     60 mL
   TF:
   IVF:
                                                                  1,452 mL
                                                                    376 mL
   Blood products:
   Total out:
                                                                  1,860 mL
                                                                    220 mL
   Urine:
                                                                  1,860 mL
                                                                    220 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    842 mL
                                                                    216 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 740 (740 - 740) mL
   PS : 10 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 70%
   PIP: 15 cmH2O
   SpO2: 98%
   ABG: ///24/
   Ve: 15.3 L/min
   Physical Examination
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: No JVD
   CARDIAC: RRR, with loud S2, crescendo-decrescendo murmur at LUSB
   LUNGS: Diffuse rales in posterior lung fields, obscured by BiPAP
   ABDOMEN: Soft, RLQ TTP.  Voluntary guarding.  No rebound.
   EXTREMITIES: No c/c/e. No femoral bruits.
   Neuro:  Moves all 4 with commands.  [**1-23**] handgrip on R, 0/5 on L.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   220 K/uL
   7.9 g/dL
   131 mg/dL
   1.2 mg/dL
   24 mEq/L
   3.8 mEq/L
   19 mg/dL
   107 mEq/L
   136 mEq/L
   23.3 %
   14.1 K/uL
        [image002.jpg]
                            [**2114-11-2**]  05:00 PM
                            [**2114-11-2**]  09:28 PM
                            [**2114-11-3**]  03:10 AM
                            [**2114-11-3**]  03:22 PM
                            [**2114-11-3**]  06:17 PM
                            [**2114-11-4**]  05:23 AM
                            [**2114-11-4**]  11:52 AM
                            [**2114-11-5**]  05:32 AM
   WBC
   20.8
   25.0
   21.3
   14.1
   Hct
   29.3
   25.9
   32
   26.7
   24.8
   23.3
   Plt
   [**Telephone/Fax (3) 6523**]20
   Cr
   1.0
   1.0
   1.2
   1.2
   TropT
   0.05
   TCO2
   24
   Glucose
   130
   155
   133
   131
   Other labs: PT / PTT / INR:14.9/41.1/1.3, CK / CKMB /
   Troponin-T:58//0.05, ALT / AST:33/62, Alk Phos / T Bili:99/0.4, Amylase
   / Lipase:49/53, Differential-Neuts:86.5 %, Lymph:7.7 %, Mono:4.6 %,
   Eos:0.9 %, Lactic Acid:2.7 mmol/L, Albumin:2.9 g/dL, LDH:462 IU/L,
   Ca++:8.0 mg/dL, Mg++:2.0 mg/dL, PO4:1.3 mg/dL
   Assessment and Plan
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed, now made
   CMO
   # Prosthetic Mitral Valve Thrombus:  Echocardiogram consistent with
   thrombus on prosthetic MV valve and fluroscopy shows one leaflet that
   is fixed.  Patient has TTE during admission at [**Hospital1 1817**] three weeks ago
   that was negative for valvular thrombus.  TTE shows gradient pressures
   of Mitral 28/(mean)18 and Aortic 45/(mean)23.  Given the patient had
   recently had a hemorrhagic stroke and recent GI bleed, the management
   will be difficult.  Patient had resumed coumadin on transfer to
   rehabilitation to prevent further clots.  Patient would likely be a
   poor surgical candidate.  This issue represents an end-stage disease
   and this is understood by family and they have elected to make the
   patient DNR/DNI and CMO.
   - Will continue Heparin gtt
   - Palliative care consult
   - Goal to get home with family, respiratory support and pain control
   # Acute Congestive Heart Failure:  Secondary to Mitral valve thrombus
   and atrial fibrillation.  Patient has high gradient between LA and LV,
   also not filling well secondary to functional stenosis secondary to
   thrombus.   Good response to low-dose IV metoprolol.
   - PO metoprolol 25 mg TID.
   - Bumex 1 mg [**Hospital1 **], which is
 home dose with goal of even
   # GI bleed:  Unclear source, likely lower GI.  HCT dropped from 29 to
   25 this AM and was subsequently transfused.  Hct responded
   appropriately but then came back down.
   -          stop lab draws
   # Atrial Fibrillation:  Poorly rate controlled.  Dig level 1.1, likely
   toxic level in this patient in light of her EKG changes.
   - Will cont BB
   # CORONARIES:  h/o CAD documented in OSH records, however patient had
   cath in [**2109**] that showed normal coronaries. Pt had STD on EKG possibly
   in setting of GI Bleed/demand or related to digoxin toxicity.
   # PUMP:  Previous TTE at [**Hospital1 1817**] 3 wks ago showed EF of 50% with no
   thrombus, with presence of dilated left atrium.
   # RLL Pneumonia:  Possible cause of her elevated WBC of 25 this AM.
   Lactate 1.3.  WBC at OSH was elevated.  Afebrile.  Not apparent that
   BCx obtained at OSH.  In context of thrombus, differential includes
   infected thrombus for leukocytosis.  C. diff negatibe
   - BCx and UCx pending
   - discontinue Vanco and Meropenem
   # HTN:  BP 108/43.  SBPs on admission in 80s.
   - Cont BB.
   # Hypothyroidism:  Continue home synthroid.
   # s/p hemorrhagic stroke:  Patient with neurological deficits on exam.
   Patient at risk for further embolic event with thrombus.
   FEN: Low salt, thickened liquids, advance to full
   ACCESS: 18 gauge PIV and R IJ
   PROPHYLAXIS:
   -DVT ppx with Hep gtt, IV PPI
   CODE: DNR/DNI, CMO
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:  Oral meds
   Lines:
   Multi Lumen - [**2114-11-3**] 06:02 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed
   24 Hour Events:
   Heparin d/c
ed.  Patient made DNR/DNI, family considering CMO if
   patient worsens.
   Allergies:
   Lasix (Oral) (Furosemide)
   Hives;
   Codeine
   Rash;
   Ceclor (Oral) (Cefaclor)
   Unknown;
   Keflex (Oral) (Cephalexin Monohydrate)
   Rash;
   Voltaren (Oral) (Diclofenac Sodium)
   Unknown;
   Penicillins
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2114-11-4**] 01:59 AM
   Vancomycin - [**2114-11-5**] 12:00 AM
   Meropenem - [**2114-11-5**] 02:00 AM
   I
   Other ICU medications:
   Morphine Sulfate - [**2114-11-4**] 04:29 PM
   Other medications:
   SSI
   Simvastatin 40mg
   Buproprion 150mg
   Paroxetene 30mg
   Gabapentin 300mg TID
   Fluticasone/Salmertol discus
   Levothyroxine 25mcg
   Vancomycin 1g q12hrs
   Pantoprazole 40mg q12hrs
   Meropenem IV q6hrs x 48hts
   Digoxin 0.125mg daily
   Bumetanide 1mg [**Hospital1 **]
   Lopressor 25mg TID
   Clonazepam 0.5mg TID
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2114-11-5**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.2
C (100.7
   Tcurrent: 36.9
C (98.5
   HR: 88 (80 - 109) bpm
   BP: 86/49(55) {79/36(48) - 106/63(72)} mmHg
   RR: 23 (23 - 33) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 83.9 kg (admission): 85.6 kg
    CVP: 9 (-5 - 222)mmHg
   Total In:
                                                                  2,702 mL
                                                                    436 mL
   PO:
                                                                    950 mL
                                                                     60 mL
   TF:
   IVF:
                                                                  1,452 mL
                                                                    376 mL
   Blood products:
   Total out:
                                                                  1,860 mL
                                                                    220 mL
   Urine:
                                                                  1,860 mL
                                                                    220 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    842 mL
                                                                    216 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 740 (740 - 740) mL
   PS : 10 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 70%
   PIP: 15 cmH2O
   SpO2: 98%
   ABG: ///24/
   Ve: 15.3 L/min
   Physical Examination
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: No JVD
   CARDIAC: RRR, with loud S2, crescendo-decrescendo murmur at LUSB
   LUNGS: Diffuse rales in posterior lung fields, obscured by BiPAP
   ABDOMEN: Soft, RLQ TTP.  Voluntary guarding.  No rebound.
   EXTREMITIES: No c/c/e. No femoral bruits.
   Neuro:  Moves all 4 with commands.  [**1-23**] handgrip on R, 0/5 on L.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   220 K/uL
   7.9 g/dL
   131 mg/dL
   1.2 mg/dL
   24 mEq/L
   3.8 mEq/L
   19 mg/dL
   107 mEq/L
   136 mEq/L
   23.3 %
   14.1 K/uL
        [image002.jpg]
                            [**2114-11-2**]  05:00 PM
                            [**2114-11-2**]  09:28 PM
                            [**2114-11-3**]  03:10 AM
                            [**2114-11-3**]  03:22 PM
                            [**2114-11-3**]  06:17 PM
                            [**2114-11-4**]  05:23 AM
                            [**2114-11-4**]  11:52 AM
                            [**2114-11-5**]  05:32 AM
   WBC
   20.8
   25.0
   21.3
   14.1
   Hct
   29.3
   25.9
   32
   26.7
   24.8
   23.3
   Plt
   [**Telephone/Fax (3) 6523**]20
   Cr
   1.0
   1.0
   1.2
   1.2
   TropT
   0.05
   TCO2
   24
   Glucose
   130
   155
   133
   131
   Other labs: PT / PTT / INR:14.9/41.1/1.3, CK / CKMB /
   Troponin-T:58//0.05, ALT / AST:33/62, Alk Phos / T Bili:99/0.4, Amylase
   / Lipase:49/53, Differential-Neuts:86.5 %, Lymph:7.7 %, Mono:4.6 %,
   Eos:0.9 %, Lactic Acid:2.7 mmol/L, Albumin:2.9 g/dL, LDH:462 IU/L,
   Ca++:8.0 mg/dL, Mg++:2.0 mg/dL, PO4:1.3 mg/dL
   Assessment and Plan
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed, now made
   CMO
   # Prosthetic Mitral Valve Thrombus:  Echocardiogram consistent with
   thrombus on prosthetic MV valve and fluroscopy shows one leaflet that
   is fixed.  Patient has TTE during admission at [**Hospital1 1817**] three weeks ago
   that was negative for valvular thrombus.  TTE shows gradient pressures
   of Mitral 28/(mean)18 and Aortic 45/(mean)23.  Given the patient had
   recently had a hemorrhagic stroke and recent GI bleed, the management
   will be difficult.  Patient had resumed coumadin on transfer to
   rehabilitation to prevent further clots.  Patient would likely be a
   poor surgical candidate.  This issue represents an end-stage disease
   and this is understood by family and they have elected to make the
   patient DNR/DNI and CMO.
   - Will continue Heparin gtt
   - Palliative care consult
   - Goal to get home with family, respiratory support and pain control
   # Acute Congestive Heart Failure:  Secondary to Mitral valve thrombus
   and atrial fibrillation.  Patient has high gradient between LA and LV,
   also not filling well secondary to functional stenosis secondary to
   thrombus.   Good response to low-dose IV metoprolol.
   - PO metoprolol 25 mg TID.
   - Bumex 1 mg [**Hospital1 **], which is
 home dose with goal of even
   # GI bleed:  Unclear source, likely lower GI.  HCT dropped from 29 to
   25 this AM and was subsequently transfused.  Hct responded
   appropriately but then came back down.
   -          stop lab draws
   # Atrial Fibrillation:  Poorly rate controlled.  Dig level 1.1, likely
   toxic level in this patient in light of her EKG changes.
   - Will cont BB
   # CORONARIES:  h/o CAD documented in OSH records, however patient had
   cath in [**2109**] that showed normal coronaries. Pt had STD on EKG possibly
   in setting of GI Bleed/demand or related to digoxin toxicity.
   # PUMP:  Previous TTE at [**Hospital1 1817**] 3 wks ago showed EF of 50% with no
   thrombus, with presence of dilated left atrium.
   # RLL Pneumonia:  Possible cause of her elevated WBC of 25 this AM.
   Lactate 1.3.  WBC at OSH was elevated.  Afebrile.  Not apparent that
   BCx obtained at OSH.  In context of thrombus, differential includes
   infected thrombus for leukocytosis.  C. diff negatibe
   - BCx and UCx pending
   - discontinue Vanco and Meropenem
   # HTN:  BP 108/43.  SBPs on admission in 80s.
   - Cont BB.
   # Hypothyroidism:  Continue home synthroid.
   # s/p hemorrhagic stroke:  Patient with neurological deficits on exam.
   Patient at risk for further embolic event with thrombus.
   FEN: Low salt, thickened liquids, advance to full
   ACCESS: 18 gauge PIV and R IJ
   PROPHYLAXIS:
   -DVT ppx with Hep gtt, IV PPI
   CODE: DNR/DNI, CMO
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:  Oral meds
   Lines:
   Multi Lumen - [**2114-11-3**] 06:02 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 66-year-old female who had a stroke with hemorrhagic evolution and was transferred to the ICU with mitral valve thrombosis and gastrointestinal bleeding. She was previously treated with anticoagulation therapy and had a prosthetic mitral valve. The patient has atrial fibrillation, which is poorly rate-controlled, and has a history of coronary artery disease. She also has hypertension, hypothyroidism, and a recent hemorrhagic stroke with neurological deficits.

The patient's current condition is critical, with a high risk of further embolic events and bleeding complications. She has a prosthetic mitral valve thrombus, which is causing acute congestive heart failure and atrial fibrillation. The patient's gastrointestinal bleeding is unclear in origin, and she has a low white blood cell count.

The patient's laboratory results show:

* Hemoglobin: 7.9 g/dL
* Platelet count: 20,000/μL
* White blood cell count: 20.8/μL
* Creatinine: 1.0 mg/dL
* Troponin-T: 0.05 ng/mL
* Lactic acid: 2.7 mmol/L
* Albumin: 2.9 g/dL
* LDH: 462 IU/L
* Calcium: 8.0 mg/dL
* Magnesium: 2.0 mg/dL
* Phosphorus: 1.3 mg/dL

Potential medical complications:

1. Further embolic events: The patient's prosthetic mitral valve thrombus and atrial fibrillation increase her risk of further embolic events, which could lead to stroke, myocardial infarction, or other cardiovascular complications.
2. Bleeding complications: The patient's gastrointestinal bleeding and low platelet count increase her risk of bleeding complications, which could lead to hypovolemic shock, organ failure, or death.
3. Infection: The patient's low white blood cell count and recent use of antibiotics increase her risk of infection, which could lead to sepsis, organ failure, or death.
4. Heart failure: The patient's acute congestive heart failure and atrial fibrillation increase her risk of heart failure, which could lead to cardiogenic shock, organ failure, or death.
5. Respiratory failure: The patient's respiratory support and pneumonia increase her risk of respiratory failure, which could lead to hypoxemic respiratory failure, hypercapnic respiratory failure, or death.

Recommendations:

1. Continue anticoagulation therapy to prevent further thrombus formation and embolic events.
2. Monitor the patient's platelet count and bleeding risk closely and adjust anticoagulation therapy accordingly.
3. Continue antibiotics to treat the patient's pneumonia and prevent further infection.
4. Monitor the patient's heart rate and rhythm closely and adjust anticoagulation therapy accordingly.
5. Consider palliative care consult to discuss the patient's end-of-life care and goals.
6. Continue to monitor the patient's respiratory status and adjust respiratory support as needed.
7. Consider transfer to a rehabilitation facility or hospice care if the patient's condition improves or if her goals change."
139476.0,203250,2114-11-05 07:41:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed
   24 Hour Events:
   Heparin d/c
ed.  Patient made DNR/DNI, family considering CMO if
   patient worsens.
   Allergies:
   Lasix (Oral) (Furosemide)
   Hives;
   Codeine
   Rash;
   Ceclor (Oral) (Cefaclor)
   Unknown;
   Keflex (Oral) (Cephalexin Monohydrate)
   Rash;
   Voltaren (Oral) (Diclofenac Sodium)
   Unknown;
   Penicillins
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2114-11-4**] 01:59 AM
   Vancomycin - [**2114-11-5**] 12:00 AM
   Meropenem - [**2114-11-5**] 02:00 AM
   I
   Other ICU medications:
   Morphine Sulfate - [**2114-11-4**] 04:29 PM
   Other medications:
   SSI
   Simvastatin 40mg
   Buproprion 150mg
   Paroxetene 30mg
   Gabapentin 300mg TID
   Fluticasone/Salmertol discus
   Levothyroxine 25mcg
   Vancomycin 1g q12hrs
   Pantoprazole 40mg q12hrs
   Meropenem IV q6hrs x 48hts
   Digoxin 0.125mg daily
   Bumetanide 1mg [**Hospital1 **]
   Lopressor 25mg TID
   Clonazepam 0.5mg TID
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2114-11-5**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.2
C (100.7
   Tcurrent: 36.9
C (98.5
   HR: 88 (80 - 109) bpm
   BP: 86/49(55) {79/36(48) - 106/63(72)} mmHg
   RR: 23 (23 - 33) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 83.9 kg (admission): 85.6 kg
    CVP: 9 (-5 - 222)mmHg
   Total In:
                                                                  2,702 mL
                                                                    436 mL
   PO:
                                                                    950 mL
                                                                     60 mL
   TF:
   IVF:
                                                                  1,452 mL
                                                                    376 mL
   Blood products:
   Total out:
                                                                  1,860 mL
                                                                    220 mL
   Urine:
                                                                  1,860 mL
                                                                    220 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    842 mL
                                                                    216 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 740 (740 - 740) mL
   PS : 10 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 70%
   PIP: 15 cmH2O
   SpO2: 98%
   ABG: ///24/
   Ve: 15.3 L/min
   Physical Examination
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: No JVD
   CARDIAC: RRR, with loud S2, crescendo-decrescendo murmur at LUSB
   LUNGS: Diffuse rales in posterior lung fields, obscured by BiPAP
   ABDOMEN: Soft, RLQ TTP.  Voluntary guarding.  No rebound.
   EXTREMITIES: No c/c/e. No femoral bruits.
   Neuro:  Moves all 4 with commands.  [**1-23**] handgrip on R, 0/5 on L.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   220 K/uL
   7.9 g/dL
   131 mg/dL
   1.2 mg/dL
   24 mEq/L
   3.8 mEq/L
   19 mg/dL
   107 mEq/L
   136 mEq/L
   23.3 %
   14.1 K/uL
        [image002.jpg]
                            [**2114-11-2**]  05:00 PM
                            [**2114-11-2**]  09:28 PM
                            [**2114-11-3**]  03:10 AM
                            [**2114-11-3**]  03:22 PM
                            [**2114-11-3**]  06:17 PM
                            [**2114-11-4**]  05:23 AM
                            [**2114-11-4**]  11:52 AM
                            [**2114-11-5**]  05:32 AM
   WBC
   20.8
   25.0
   21.3
   14.1
   Hct
   29.3
   25.9
   32
   26.7
   24.8
   23.3
   Plt
   [**Telephone/Fax (3) 6523**]20
   Cr
   1.0
   1.0
   1.2
   1.2
   TropT
   0.05
   TCO2
   24
   Glucose
   130
   155
   133
   131
   Other labs: PT / PTT / INR:14.9/41.1/1.3, CK / CKMB /
   Troponin-T:58//0.05, ALT / AST:33/62, Alk Phos / T Bili:99/0.4, Amylase
   / Lipase:49/53, Differential-Neuts:86.5 %, Lymph:7.7 %, Mono:4.6 %,
   Eos:0.9 %, Lactic Acid:2.7 mmol/L, Albumin:2.9 g/dL, LDH:462 IU/L,
   Ca++:8.0 mg/dL, Mg++:2.0 mg/dL, PO4:1.3 mg/dL
   Assessment and Plan
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed
   # Prosthetic Mitral Valve Thrombus:  Echocardiogram consistent with
   thrombus on prosthetic MV valve and fluroscopy shows one leaflet that
   is fixed.  Patient has TTE during admission at [**Hospital1 1817**] three weeks ago
   that was negative for valvular thrombus.  TTE shows gradient pressures
   of Mitral 28/(mean)18 and Aortic 45/(mean)23.  Given the patient had
   recently had a hemorrhagic stroke and recent GI bleed, the management
   will be difficult.  Patient had resumed coumadin on transfer to
   rehabilitation to prevent further clots.  Patient would likely be a
   poor surgical candidate.  This issue represents an end-stage disease
   and this is understood by family.
   - Will continue Heparin gtt
   - Palliative care consult
   - Goal to get home with family, respiratory support and pain control
   # Acute Congestive Heart Failure:  Secondary to Mitral valve thrombus
   and atrial fibrillation.  Patient has high gradient between LA and LV,
   also not filling well secondary to functional stenosis secondary to
   thrombus.   Good response to low-dose IV metoprolol.
   - PO metoprolol 25 mg TID.
   - Bumex 1 mg [**Hospital1 **], which is
 home dose with goal of even
   # GI bleed:  Unclear source, likely lower GI.  HCT dropped from 29 to
   25 this AM and was subsequently transfused.  Hct responded
   appropriately but then came back down.
   - GI recs for endoscopy
   - Transfusion for symptomatic anemia
   # Atrial Fibrillation:  Poorly rate controlled.  Dig level 1.1, likely
   toxic level in this patient in light of her EKG changes.
   - Will start BB
   - Heparin gtt for further thrombus progression
   .
   # CORONARIES:  h/o CAD documented in OSH records, however patient had
   cath in [**2109**] that showed normal coronaries. Pt had STD on EKG possibly
   in setting of GI Bleed/demand or related to digoxin toxicity.
   # PUMP:  Previous TTE at [**Hospital1 1817**] 3 wks ago showed EF of 50% with no
   thrombus, with presence of dilated left atrium.
   - TEE today
   # RLL Pneumonia:  Possible cause of her elevated WBC of 25 this AM.
   Lactate 1.3.  WBC at OSH was elevated.  Afebrile.  Not apparent that
   BCx obtained at OSH.  In context of thrombus, differential includes
   infected thrombus for leukocytosis.  C. diff negatibe
   - BCx and UCx pending
   - Continue Vanco and Meropenem
   - D/C flagyl
   # HTN:  BP 108/43.  SBPs on admission in 80s.
   - Start BB.
   # Hypothyroidism:  Continue home synthroid.
   # s/p hemorrhagic stroke:  Patient with neurological deficits on exam.
   Patient at risk for further embolic event with thrombus.
   FEN: Low salt, thickened liquids, advance to full
   ACCESS: 18 gauge PIV and R IJ
   PROPHYLAXIS:
   -DVT ppx with Hep gtt, IV PPI
   CODE: DNR/DNI
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2114-11-3**] 06:02 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed
   24 Hour Events:
   Heparin d/c
ed.  Patient made DNR/DNI, family considering CMO if
   patient worsens.
   Allergies:
   Lasix (Oral) (Furosemide)
   Hives;
   Codeine
   Rash;
   Ceclor (Oral) (Cefaclor)
   Unknown;
   Keflex (Oral) (Cephalexin Monohydrate)
   Rash;
   Voltaren (Oral) (Diclofenac Sodium)
   Unknown;
   Penicillins
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2114-11-4**] 01:59 AM
   Vancomycin - [**2114-11-5**] 12:00 AM
   Meropenem - [**2114-11-5**] 02:00 AM
   I
   Other ICU medications:
   Morphine Sulfate - [**2114-11-4**] 04:29 PM
   Other medications:
   SSI
   Simvastatin 40mg
   Buproprion 150mg
   Paroxetene 30mg
   Gabapentin 300mg TID
   Fluticasone/Salmertol discus
   Levothyroxine 25mcg
   Vancomycin 1g q12hrs
   Pantoprazole 40mg q12hrs
   Meropenem IV q6hrs x 48hts
   Digoxin 0.125mg daily
   Bumetanide 1mg [**Hospital1 **]
   Lopressor 25mg TID
   Clonazepam 0.5mg TID
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2114-11-5**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.2
C (100.7
   Tcurrent: 36.9
C (98.5
   HR: 88 (80 - 109) bpm
   BP: 86/49(55) {79/36(48) - 106/63(72)} mmHg
   RR: 23 (23 - 33) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 83.9 kg (admission): 85.6 kg
    CVP: 9 (-5 - 222)mmHg
   Total In:
                                                                  2,702 mL
                                                                    436 mL
   PO:
                                                                    950 mL
                                                                     60 mL
   TF:
   IVF:
                                                                  1,452 mL
                                                                    376 mL
   Blood products:
   Total out:
                                                                  1,860 mL
                                                                    220 mL
   Urine:
                                                                  1,860 mL
                                                                    220 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    842 mL
                                                                    216 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 740 (740 - 740) mL
   PS : 10 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 70%
   PIP: 15 cmH2O
   SpO2: 98%
   ABG: ///24/
   Ve: 15.3 L/min
   Physical Examination
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: No JVD
   CARDIAC: RRR, with loud S2, crescendo-decrescendo murmur at LUSB
   LUNGS: Diffuse rales in posterior lung fields, obscured by BiPAP
   ABDOMEN: Soft, RLQ TTP.  Voluntary guarding.  No rebound.
   EXTREMITIES: No c/c/e. No femoral bruits.
   Neuro:  Moves all 4 with commands.  [**1-23**] handgrip on R, 0/5 on L.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   220 K/uL
   7.9 g/dL
   131 mg/dL
   1.2 mg/dL
   24 mEq/L
   3.8 mEq/L
   19 mg/dL
   107 mEq/L
   136 mEq/L
   23.3 %
   14.1 K/uL
        [image002.jpg]
                            [**2114-11-2**]  05:00 PM
                            [**2114-11-2**]  09:28 PM
                            [**2114-11-3**]  03:10 AM
                            [**2114-11-3**]  03:22 PM
                            [**2114-11-3**]  06:17 PM
                            [**2114-11-4**]  05:23 AM
                            [**2114-11-4**]  11:52 AM
                            [**2114-11-5**]  05:32 AM
   WBC
   20.8
   25.0
   21.3
   14.1
   Hct
   29.3
   25.9
   32
   26.7
   24.8
   23.3
   Plt
   [**Telephone/Fax (3) 6523**]20
   Cr
   1.0
   1.0
   1.2
   1.2
   TropT
   0.05
   TCO2
   24
   Glucose
   130
   155
   133
   131
   Other labs: PT / PTT / INR:14.9/41.1/1.3, CK / CKMB /
   Troponin-T:58//0.05, ALT / AST:33/62, Alk Phos / T Bili:99/0.4, Amylase
   / Lipase:49/53, Differential-Neuts:86.5 %, Lymph:7.7 %, Mono:4.6 %,
   Eos:0.9 %, Lactic Acid:2.7 mmol/L, Albumin:2.9 g/dL, LDH:462 IU/L,
   Ca++:8.0 mg/dL, Mg++:2.0 mg/dL, PO4:1.3 mg/dL
   Assessment and Plan
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed
   # Prosthetic Mitral Valve Thrombus:  Echocardiogram consistent with
   thrombus on prosthetic MV valve and fluroscopy shows one leaflet that
   is fixed.  Patient has TTE during admission at [**Hospital1 1817**] three weeks ago
   that was negative for valvular thrombus.  TTE shows gradient pressures
   of Mitral 28/(mean)18 and Aortic 45/(mean)23.  Given the patient had
   recently had a hemorrhagic stroke and recent GI bleed, the management
   will be difficult.  Patient had resumed coumadin on transfer to
   rehabilitation to prevent further clots.  Patient would likely be a
   poor surgical candidate.  This issue represents an end-stage disease
   and this is understood by family.
   - Will continue Heparin gtt
   - Palliative care consult
   - Goal to get home with family, respiratory support and pain control
   # Acute Congestive Heart Failure:  Secondary to Mitral valve thrombus
   and atrial fibrillation.  Patient has high gradient between LA and LV,
   also not filling well secondary to functional stenosis secondary to
   thrombus.   Good response to low-dose IV metoprolol.
   - PO metoprolol 25 mg TID.
   - Bumex 1 mg [**Hospital1 **], which is
 home dose with goal of even
   # GI bleed:  Unclear source, likely lower GI.  HCT dropped from 29 to
   25 this AM and was subsequently transfused.  Hct responded
   appropriately but then came back down.
   - GI recs for endoscopy
   - Transfusion for symptomatic anemia
   # Atrial Fibrillation:  Poorly rate controlled.  Dig level 1.1, likely
   toxic level in this patient in light of her EKG changes.
   - Will start BB
   - Heparin gtt for further thrombus progression
   .
   # CORONARIES:  h/o CAD documented in OSH records, however patient had
   cath in [**2109**] that showed normal coronaries. Pt had STD on EKG possibly
   in setting of GI Bleed/demand or related to digoxin toxicity.
   # PUMP:  Previous TTE at [**Hospital1 1817**] 3 wks ago showed EF of 50% with no
   thrombus, with presence of dilated left atrium.
   - TEE today
   # RLL Pneumonia:  Possible cause of her elevated WBC of 25 this AM.
   Lactate 1.3.  WBC at OSH was elevated.  Afebrile.  Not apparent that
   BCx obtained at OSH.  In context of thrombus, differential includes
   infected thrombus for leukocytosis.  C. diff negatibe
   - BCx and UCx pending
   - Continue Vanco and Meropenem
   - D/C flagyl
   # HTN:  BP 108/43.  SBPs on admission in 80s.
   - Start BB.
   # Hypothyroidism:  Continue home synthroid.
   # s/p hemorrhagic stroke:  Patient with neurological deficits on exam.
   Patient at risk for further embolic event with thrombus.
   FEN: Low salt, thickened liquids, advance to full
   ACCESS: 18 gauge PIV and R IJ
   PROPHYLAXIS:
   -DVT ppx with Hep gtt, IV PPI
   CODE: DNR/DNI
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2114-11-3**] 06:02 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, I have summarized the following information:

**Medical History:**

* 66-year-old female patient with a history of CVA (cerebrovascular accident) with hemorrhagic evolution, AV and MV valves transferred from OSH (outpatient surgery hospital) with MV thrombosis and GI bleed.
* Previous TTE (transthoracic echocardiogram) showed EF (ejection fraction) of 50% with no thrombus, with presence of dilated left atrium.
* Patient has a history of CAD (coronary artery disease) documented in OSH records, but cath (cardiac catheterization) in 2109 showed normal coronaries.

**Current Condition:**

* Patient has a prosthetic mitral valve thrombus, which is causing acute congestive heart failure (ACHF) secondary to mitral valve thrombus and atrial fibrillation.
* Patient has high gradient between LA (left atrium) and LV (left ventricle), not filling well secondary to functional stenosis secondary to thrombus.
* Patient has poorly rate-controlled atrial fibrillation, with Dig level 1.1, likely toxic level in this patient in light of her EKG changes.
* Patient has a GI bleed, unclear source, likely lower GI, with HCT (hematocrit) dropped from 29 to 25 this morning and was subsequently transfused.
* Patient has an elevated WBC (white blood cell count) of 25 this morning, possibly due to RLL (right lower lobe) pneumonia or infected thrombus.

**Current Medications:**

* Heparin gtt (infusion) for further thrombus progression
* Vancomycin and Meropenem for suspected infected thrombus
* PO metoprolol 25 mg TID for ACHF
* Bumex 1 mg [**Hospital1**] for ACHF
* Digoxin 0.125 mg daily for atrial fibrillation
* Lopressor 25 mg TID for hypertension
* Clonazepam 0.5 mg TID for anxiety

**Potential Medical Complications:**

1. Further thrombus progression: Patient's prosthetic mitral valve thrombus may continue to progress, leading to worsening heart failure and increased risk of embolic events.
2. Infected thrombus: Patient's elevated WBC count and suspected infected thrombus may lead to sepsis and organ dysfunction.
3. Atrial fibrillation: Patient's poorly rate-controlled atrial fibrillation may lead to further cardiac complications, including heart failure and stroke.
4. GI bleed: Patient's ongoing GI bleed may lead to anemia, electrolyte imbalances, and other complications.
5. Hypothyroidism: Patient's hypothyroidism may lead to further complications, including decreased cardiac function and increased risk of infections.
6. Hypertension: Patient's hypertension may lead to further cardiac complications, including heart failure and stroke.

**Assessment and Plan:**

* Continue Heparin gtt for further thrombus progression
* Palliative care consult
* Goal to get home with family, respiratory support, and pain control
* Continue PO metoprolol 25 mg TID for ACHF
* Continue Bumex 1 mg [**Hospital1**] for ACHF
* Start BB (beta blocker) for atrial fibrillation
* Continue Vancomycin and Meropenem for suspected infected thrombus
* D/C (discontinue) Flagyl
* Start prophylaxis for DVT (deep vein thrombosis) and VAP (ventilator-associated pneumonia)
* Continue to monitor patient's condition and adjust plan as necessary."
